Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term:Neoplasm Metastasis
go back to main search page
Accession:DOID:9000965 term browser browse the term
Definition:The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
Synonyms:exact_synonym: Metastases;   Metastasis;   Neoplasm Metastases
 primary_id: MESH:D009362
 xref: EFO:0009708;   EFO:0009709;   EFO:0010941


show annotations for term's descendants           Sort by:
Neoplasm Metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12015757 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727 		JBrowse link
G ABCC4 ATP binding cassette subfamily C member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17003774 NCBI chr22:45,767,033...46,013,577
Ensembl chr22:45,765,835...46,013,505 		JBrowse link
G ACE angiotensin I converting enzyme ISO CTD Direct Evidence: marker/mechanism CTD PMID:18059164 NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358 		JBrowse link
G ACKR3 atypical chemokine receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22180778 NCBI chr25:47,327,921...47,339,632
Ensembl chr25:47,327,963...47,339,622 		JBrowse link
G ACSBG1 acyl-CoA synthetase bubblegum family member 1 ISO associated with pheochromocytoma RGD PMID:29067245 RGD:13831131 NCBI chr 3:58,319,222...58,367,087
Ensembl chr 3:58,319,376...58,366,854 		JBrowse link
G ACVR2A activin A receptor type 2A exacerbates ISO associated with colon cancer;mRNA,protein:decreased expression:colon (human) RGD PMID:30310521 RGD:151361136 NCBI chr19:49,642,429...49,726,720
Ensembl chr19:49,641,219...49,723,420 		JBrowse link
G ADGRB1 adhesion G protein-coupled receptor B1 ISO associated with colorectal cancer RGD PMID:9772287 RGD:13831353 NCBI chr13:36,627,791...36,649,013
Ensembl chr13:36,614,498...36,690,936 		JBrowse link
G ADORA2B adenosine A2b receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:27590504 NCBI chr 5:39,884,375...39,908,214 JBrowse link
G AGTR1 angiotensin II receptor type 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18059164 NCBI chr23:43,569,658...43,617,113
Ensembl chr23:43,614,035...43,616,238 		JBrowse link
G AGTR2 angiotensin II receptor type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18059164 NCBI chr  X:88,703,551...88,708,451
Ensembl chr  X:88,705,765...88,706,853 		JBrowse link
G AHR aryl hydrocarbon receptor ISO CTD Direct Evidence: therapeutic CTD PMID:21948867 NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444 		JBrowse link
G AKIRIN2 akirin 2 ISO RGD PMID:18460465 RGD:2306009 NCBI chr12:47,113,856...47,132,800
Ensembl chr12:47,113,857...47,132,555 		JBrowse link
G AKT2 AKT serine/threonine kinase 2 ISO associated with Mammary Neoplasms, Experimental RGD PMID:19491266 RGD:2315599 NCBI chr 1:113,359,038...113,407,119
Ensembl chr 1:113,359,575...113,407,131 		JBrowse link
G ALDOA aldolase, fructose-bisphosphate A ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr 6:18,077,241...18,083,053 JBrowse link
G ALK ALK receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:22986231 PMID:22999080 NCBI chr17:23,010,308...23,688,841
Ensembl chr17:23,010,308...23,688,841 		JBrowse link
G ALOX5 arachidonate 5-lipoxygenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:20061081 NCBI chr28:2,170,920...2,218,765
Ensembl chr28:2,170,920...2,219,609 		JBrowse link
G AMIGO2 adhesion molecule with Ig like domain 2 ISO Liver Metastasis RGD PMID:28272394 RGD:14394499 NCBI chr27:7,507,426...7,510,015
Ensembl chr27:7,507,489...7,509,054 		JBrowse link
G ANGPTL4 angiopoietin like 4 ISO CTD Direct Evidence: therapeutic CTD PMID:17130448 NCBI chr20:52,942,090...52,948,126
Ensembl chr20:52,942,259...52,947,475 		JBrowse link
G ANTXR1 ANTXR cell adhesion molecule 1 ISO associated with Mammary Neoplasms, Experimental; RGD PMID:22085271 RGD:9684855 NCBI chr10:67,829,573...68,021,368
Ensembl chr10:67,829,225...68,019,127 		JBrowse link
G ANXA1 annexin A1 treatment ISO associated with Mammary Neoplasms, Experimental
associated with Mammary Neoplasms, Experimental;protein:increased expression:lung
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:9514092 PMID:20308542 PMID:20821804 RGD:2306939 RGD:7421541 RGD:7421563 NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011 		JBrowse link
G ANXA4 annexin A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr10:68,418,678...68,466,181
Ensembl chr10:68,431,056...68,466,174 		JBrowse link
G ANXA7 annexin A7 ISO associated with Breast Neoplasms;protein:increased expression:breast
associated with Prostatic Neoplasms;protein:decreased expression:prostate gland		 RGD PMID:11287641 PMID:15073110 RGD:2292655 RGD:2292656 NCBI chr 4:23,933,959...23,961,968
Ensembl chr 4:23,934,234...23,961,880 		JBrowse link
G APOE apolipoprotein E ISO RGD PMID:22469977 RGD:7771597 NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440 		JBrowse link
G ARHGDIA Rho GDP dissociation inhibitor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr 9:419,350...422,284
Ensembl chr 9:419,413...423,252 		JBrowse link
G ARID1A AT-rich interaction domain 1A disease_progression ISO in lung; associated with hepatocellular carcinoma RGD PMID:25975202 RGD:125097495 NCBI chr 2:73,331,606...73,401,151
Ensembl chr 2:73,324,852...73,401,102 		JBrowse link
G ATP6V1C1 ATPase H+ transporting V1 subunit C1 ISO associated with Mammary Neoplasms, Experimental RGD PMID:24155661 RGD:14700647 NCBI chr13:4,509,699...4,569,500
Ensembl chr13:4,510,003...4,579,846 		JBrowse link
G AXL AXL receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:26206560 NCBI chr 1:112,699,679...112,727,434
Ensembl chr 1:112,700,365...112,726,960 		JBrowse link
G AZIN1 antizyme inhibitor 1 ISO associated with stomach cancer;RNA:increased editing:stomach
associated with colorectal cancer;RNA:increased editing:colorectum		 RGD PMID:29925690 PMID:30563560 RGD:14700703 RGD:14700704 NCBI chr13:4,363,996...4,396,069
Ensembl chr13:4,361,340...4,396,040 		JBrowse link
G B9D2 B9 domain containing 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23146760 PMID:23992306 PMID:26896736 PMID:31381904 NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator ISO associated with Carcinoma, Infiltrating Duct RGD PMID:17288732 RGD:1643356 NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464 		JBrowse link
G BCL2 BCL2 apoptosis regulator ISO associated with Carcinoma, Renal Cell
associated with Breast Neoplasms		 RGD PMID:12810203 PMID:16826579 RGD:2293020 RGD:2293021 NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658 		JBrowse link
G BMP6 bone morphogenetic protein 6 severity ISO associated with Prostatic Neoplasms;protein:increased expression:bone RGD PMID:16166304 RGD:2289018 NCBI chr35:7,780,763...7,833,095
Ensembl chr35:7,804,231...7,831,845 		JBrowse link
G BMP7 bone morphogenetic protein 7 disease_progression ISO associated with Prostatic Neoplasms;mRNA:increased expression:bone
associated with Breast Neoplasms;protein:increased expression:breast		 RGD PMID:12539225 PMID:17895257 RGD:2289029 RGD:2289033 NCBI chr24:42,203,183...42,294,105
Ensembl chr24:42,204,823...42,294,653 		JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase onset ISO associated with Melanoma; DNA:mutations: : RGD PMID:25623140 RGD:11567259 NCBI chr16:8,222,909...8,318,179
Ensembl chr16:8,222,907...8,317,906 		JBrowse link
G BRD4 bromodomain containing 4 ISO RGD PMID:23950209 RGD:9586346 NCBI chr20:46,844,795...46,927,620
Ensembl chr20:46,891,514...46,927,608 		JBrowse link
G BRMS1 BRMS1 transcriptional repressor and anoikis regulator ISO CTD Direct Evidence: therapeutic CTD PMID:27501413 NCBI chr18:50,967,175...50,974,816
Ensembl chr18:50,967,270...50,974,321 		JBrowse link
G BSG basigin ISO CTD Direct Evidence: marker/mechanism CTD PMID:21956400 NCBI chr20:57,942,703...57,951,089
Ensembl chr20:57,943,276...57,951,061 		JBrowse link
G CAB39 calcium binding protein 39 ISO associated with hepatocellular carcinoma; RGD PMID:28605041 RGD:14398832 NCBI chr25:42,752,798...42,801,257
Ensembl chr25:42,703,332...42,799,279 		JBrowse link
G CACYBP calcyclin binding protein ISO associated with pancreatic neoplasms RGD PMID:18765951 RGD:2326146 NCBI chr 7:24,372,599...24,384,084
Ensembl chr 7:24,372,596...24,383,926 		JBrowse link
G CAP1 cyclase associated actin cytoskeleton regulatory protein 1 ISO associated with Pancreatic Neoplasms; mRNA, protein:increased expression:pancreas RGD PMID:19188911 RGD:2326238 NCBI chr15:2,886,661...2,913,975 JBrowse link
G CASP3 caspase 3 ISO associated with Breast Neoplasms RGD PMID:18064531 RGD:2293306 NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505 		JBrowse link
G CAT catalase ISO CTD Direct Evidence: therapeutic CTD PMID:12538496 PMID:22580338 PMID:23518002 NCBI chr18:33,383,005...33,422,447
Ensembl chr18:33,383,005...33,422,447 		JBrowse link
G CAV1 caveolin 1 treatment ISO associated with Mammary Neoplasms, Experimental
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:15334058 PMID:15355971 PMID:20562527 RGD:2289106 RGD:8661780 NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935 		JBrowse link
G CBX4 chromobox 4 ISO associated with Carcinoma, Hepatocellular; RGD PMID:24838576 RGD:9586738 NCBI chr 9:1,799,847...1,807,500
Ensembl chr 9:1,802,047...1,807,690 		JBrowse link
G CBX5 chromobox 5 ISO associated with Lung Neoplasms; RGD PMID:22900142 RGD:9586743 NCBI chr27:1,020,500...1,058,027
Ensembl chr27:1,039,594...1,049,788 		JBrowse link
G CCL2 C-C motif chemokine ligand 2 ISO associated with Mammary Neoplasms, Experimental RGD PMID:19629725 RGD:4891450 NCBI chr 9:39,008,187...39,009,932 JBrowse link
G CCL20 C-C motif chemokine ligand 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30603057 NCBI chr25:40,506,385...40,509,903
Ensembl chr25:40,506,753...40,509,709 		JBrowse link
G CCL5 C-C motif chemokine ligand 5 treatment ISO associated with Animal Mammary Neoplasms; RGD PMID:15692764 RGD:14995455 NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852 		JBrowse link
G CCN4 cellular communication network factor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30723155 NCBI chr13:29,648,720...29,683,822
Ensembl chr13:29,648,639...29,679,732 		JBrowse link
G CCNA2 cyclin A2 ISO associated with Seminoma;protein:increased expression:testis RGD PMID:14696091 RGD:2293346 NCBI chr19:18,317,866...18,324,592
Ensembl chr19:18,318,004...18,323,691 		JBrowse link
G CCND1 cyclin D1 treatment ISO associated with Carcinoma, Non-Small-Cell Lung;mRNA:splice variant
associated with stomach cancer; human cells in mouse model 		RGD PMID:18715616 PMID:27431311 RGD:13434926 RGD:152995400 NCBI chr18:48,501,905...48,509,684
Ensembl chr18:48,501,899...48,516,005 		JBrowse link
G CCND2 cyclin D2 ISO associated with Breast Neoplasms;DNA:hypermethylated:brain RGD PMID:15131050 RGD:2289155 NCBI chr27:40,563,306...40,593,362
Ensembl chr27:40,564,921...40,594,255 		JBrowse link
G CCNE1 cyclin E1 disease_progression ISO associated with non-small cell lung carcinoma
protein:altered processing		 RGD PMID:11212263 PMID:17671189 RGD:13673913 RGD:2289229 NCBI chr 1:121,688,622...121,697,533
Ensembl chr 1:121,688,796...121,697,649 		JBrowse link
G CCR5 C-C motif chemokine receptor 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35072892 NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952 		JBrowse link
G CD274 CD274 molecule disease_progression ISO associated with ovarian cancer RGD PMID:23340297 RGD:41410797 NCBI chr 1:93,461,735...93,605,772
Ensembl chr 1:93,585,518...93,603,522 		JBrowse link
G CD44 CD44 molecule ISO CTD Direct Evidence: marker/mechanism
associated with Carcinoma, Renal Cell;protein:increased expression:kidney		 CTD
RGD		 PMID:18026989 PMID:23098472 RGD:2289347 NCBI chr18:32,735,493...32,826,483
Ensembl chr18:32,737,907...32,827,107 		JBrowse link
G CD82 CD82 molecule ISO associated with Prostatic Neoplasms;mRNA:decreased expression
associated with Carcinoma, Infiltrating Duct;mRNA:decreased expression:brain
associated with Prostatic Neoplasms;DNA:loss of heterozygosity
CTD Direct Evidence: therapeutic
associated with Carcinoma, Hepatocellular;mRNA:decreased expression
associated with Prostatic Neoplasms;mRNA:decreased expression:bone		 RGD
CTD		 PMID:9254900 PMID:9831222 PMID:11275982 PMID:12806379 PMID:15592684 More... RGD:2289400 RGD:2289402 RGD:2289407 RGD:2289425 RGD:68869 NCBI chr18:44,658,414...44,707,897
Ensembl chr18:44,659,180...44,706,768 		JBrowse link
G CD86 CD86 molecule ISO mRNA:decreased expression:mediastinal lymph node (rat) RGD PMID:18360875 RGD:4892237 NCBI chr33:25,256,267...25,318,855
Ensembl chr33:25,256,267...25,318,087 		JBrowse link
G CDH1 cadherin 1 treatment ISO associated with Prostatic Neoplasms
associated with stomach cancer; human cells in mouse model
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:17520682 PMID:18008331 PMID:22580338 PMID:27431311 RGD:152995400 RGD:2289488 NCBI chr 5:80,757,508...80,834,878
Ensembl chr 5:80,757,508...80,834,878 		JBrowse link
G CDH2 cadherin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23876460 NCBI chr 7:60,736,760...60,950,477
Ensembl chr 7:60,736,760...60,951,034 		JBrowse link
G CDKL2 cyclin dependent kinase like 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25333262 NCBI chr32:158,140...206,860
Ensembl chr32:159,332...202,617 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A ISO associated with Melanoma; RGD PMID:9194578 RGD:8662817 NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281 		JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO associated with Paraganglioma, Extra-Adrenal;DNA:hypermethylation RGD PMID:18509008 RGD:8552280 NCBI chr11:41,223,316...41,226,056
Ensembl chr11:41,223,315...41,264,379 		JBrowse link
G CFL1 cofilin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr18:51,404,649...51,408,240
Ensembl chr18:51,401,659...51,408,212 		JBrowse link
G CGA glycoprotein hormones, alpha polypeptide ISO associated with Breast Neoplasms;protein:increased expression:serum RGD PMID:6768680 RGD:2293637 NCBI chr12:46,610,801...46,629,322
Ensembl chr12:46,610,973...46,636,640 		JBrowse link
G CHEK1 checkpoint kinase 1 ISO associated with Pancreatic Neoplasms RGD PMID:15448002 RGD:2317235 NCBI chr 5:8,878,511...8,910,626
Ensembl chr 5:8,879,147...8,907,669 		JBrowse link
G CHUK component of inhibitor of nuclear factor kappa B kinase complex ISO associated with prostate adenocarcinoma RGD PMID:17377533 RGD:2298657 NCBI chr28:12,964,670...13,001,557
Ensembl chr28:12,965,479...13,001,512 		JBrowse link
G CIC capicua transcriptional repressor ISO CTD Direct Evidence: marker/mechanism CTD PMID:27869830 NCBI chr 1:112,081,775...112,105,093
Ensembl chr 1:112,082,265...112,105,082 		JBrowse link
G CLDN7 claudin 7 ISO RGD PMID:23390083 RGD:9685143 NCBI chr 5:32,223,985...32,225,795
Ensembl chr 5:32,224,040...32,226,168 		JBrowse link
G CLIC1 chloride intracellular channel 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr12:1,209,777...1,215,229
Ensembl chr12:1,209,780...1,215,229 		JBrowse link
G CLU clusterin ISO associated with Breast Neoplasms RGD PMID:20307318 RGD:8883512 NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563 		JBrowse link
G CREB1 cAMP responsive element binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29179997 NCBI chr37:15,921,214...15,978,492
Ensembl chr37:15,939,138...15,977,556 		JBrowse link
G CSF1 colony stimulating factor 1 ISO associated with Prostatic Neoplasms RGD PMID:18510570 RGD:2293638 NCBI chr 6:42,028,454...42,047,028
Ensembl chr 6:42,034,149...42,049,371 		JBrowse link
G CSF1R colony stimulating factor 1 receptor exacerbates ISO associated with Prostatic Neoplasms
associated with breast cancer
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:1390197 PMID:18510570 PMID:25005824 RGD:150524287 RGD:2293638 NCBI chr 4:58,980,699...59,010,683
Ensembl chr 4:58,980,788...59,010,510 		JBrowse link
G CSF3 colony stimulating factor 3 ISO CTD Direct Evidence: therapeutic CTD PMID:7543699 PMID:9018096 NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108 		JBrowse link
G CSTA cystatin A ISO CTD Direct Evidence: marker/mechanism CTD PMID:20461718 NCBI chr33:25,477,789...25,489,123
Ensembl chr33:25,478,055...25,489,121 		JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 disease_progression ISO associated with Mammary Neoplasms, Experimental RGD PMID:15701862 PMID:18049334 RGD:4891518 RGD:7204722 NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874 		JBrowse link
G CTNNB1 catenin beta 1 ISO associated with Prostatic Neoplasms
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:18008331 PMID:29106415 RGD:2289488 NCBI chr23:10,559,722...10,572,933
Ensembl chr23:10,559,718...10,572,927 		JBrowse link
G CTSB cathepsin B ISO protein:increased expression:cerebrospinal fluid RGD PMID:12589965 RGD:5686394 NCBI chr25:26,048,237...26,056,570
Ensembl chr25:26,048,253...26,055,801 		JBrowse link
G CTSD cathepsin D ISO protein:increased expression:oral cavity, oropharynx, hypopharynx (human) RGD PMID:10562684 RGD:1547892 NCBI chr18:46,010,440...46,019,457
Ensembl chr18:46,010,440...46,019,457 		JBrowse link
G CTSH cathepsin H ISO protein:increased expression:cerebrospinal fluid RGD PMID:12589965 RGD:5686394 NCBI chr 3:58,103,284...58,113,958
Ensembl chr 3:58,103,291...58,113,718 		JBrowse link
G CTU1 cytosolic thiouridylase subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 1:105,795,273...105,800,722 JBrowse link
G CTU2 cytosolic thiouridylase subunit 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 5:64,640,389...64,647,298
Ensembl chr 5:64,640,389...64,647,215 		JBrowse link
G CX3CR1 C-X3-C motif chemokine receptor 1 susceptibility ISO associated with Breast Neoplasms RGD PMID:16627550 RGD:4892015 NCBI chr23:8,937,069...8,954,738
Ensembl chr23:8,938,906...8,952,808 		JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 treatment ISO associated with Pancreatic Carcinoma
CTD Direct Evidence: marker/mechanism
associated with Pancreatic Neoplasms		 RGD
CTD		 PMID:12761880 PMID:21312072 PMID:23743303 PMID:26330165 RGD:10398726 RGD:2317610 NCBI chr28:2,895,916...2,903,543 JBrowse link
G CXCR3 C-X-C motif chemokine receptor 3 ISO associated with Mammary Neoplasms, Experimental RGD PMID:16885372 RGD:5135487 NCBI chr  X:55,882,433...55,884,582
Ensembl chr  X:55,882,433...55,884,582 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 ameliorates
disease_progression
severity		 ISO associated with lung cancer; human cells in mouse model
associated with lung non-small cell carcinoma; protein:increased expression:lung (human)
associated with lung non-small cell carcinoma;mRNA,protein:increased expression:lung (human)
associated with Otorhinolaryngologic Neoplasms;mRNA,protein:increased expression:Laryngeal and hypopharyngeal tissue (human)
associated with oral squamous cell carcinoma
human cells in mouse model;associated with lung cancer
CTD Direct Evidence: marker/mechanism
associated with osteosarcoma;protein:increased expression:bone (human)
associated with pancreatic cancer		 RGD
CTD		 PMID:16230077 PMID:16322285 PMID:17634424 PMID:18487224 PMID:21312072 More... RGD:151708730 RGD:152023741 RGD:152023745 RGD:152023746 RGD:152025556 RGD:152177475 RGD:152177476 RGD:152177478 RGD:152177479 NCBI chr19:38,874,650...38,877,740
Ensembl chr19:38,874,145...38,877,740 		JBrowse link
G CYP19A1 cytochrome P450 family 19 subfamily A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28112739 NCBI chr30:16,954,020...17,056,728
Ensembl chr30:16,957,215...16,988,353 		JBrowse link
G DAB2IP DAB2 interacting protein severity ISO associated with colorectal cancer;protein:decreased expression:colorectum (human) RGD PMID:26336990 RGD:11531913 NCBI chr 9:60,725,887...60,918,242
Ensembl chr 9:60,726,809...60,918,139 		JBrowse link
G DAPK1 death associated protein kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17319784 NCBI chr 1:72,278,939...72,448,907
Ensembl chr 1:72,280,103...72,447,822 		JBrowse link
G DAXX death domain associated protein ISO RGD PMID:23539629 RGD:9587820 NCBI chr12:2,755,960...2,760,687
Ensembl chr12:2,755,960...2,761,340 		JBrowse link
G DCN decorin ISO associated with Breast Neoplasms RGD PMID:18688028 RGD:2311418 NCBI chr15:31,833,492...31,887,699
Ensembl chr15:31,833,746...31,877,417 		JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 severity ISO mRNA:increased expression:ovary (human)
protein:increased expression:bone (human)		 RGD PMID:28743276 PMID:29039472 RGD:151347541 RGD:151347601 NCBI chr12:653,800...671,190
Ensembl chr12:653,807...670,543 		JBrowse link
G DDR2 discoidin domain receptor tyrosine kinase 2 ameliorates ISO associated with melanoma; RGD PMID:24293323 RGD:150429711 NCBI chr38:20,002,984...20,152,930
Ensembl chr38:20,008,057...20,152,275 		JBrowse link
G DDX3X DEAD-box helicase 3 X-linked ISO human cells in mouse model RGD PMID:26087195 RGD:11096798 NCBI chr  X:35,759,367...35,789,759
Ensembl chr  X:35,759,416...35,789,774 		JBrowse link
G DEK DEK proto-oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr35:17,014,802...17,045,308
Ensembl chr35:17,016,231...17,044,749 		JBrowse link
G DHFR dihydrofolate reductase disease_progression ISO CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:8149482 PMID:19159907 RGD:11040442 NCBI chr 3:26,521,214...26,556,065 JBrowse link
G DIO3 iodothyronine deiodinase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26825960 NCBI chr 8:69,696,779...69,698,880 JBrowse link
G DMD dystrophin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24793134 NCBI chr  X:26,290,903...28,444,635
Ensembl chr  X:26,290,910...28,333,576 		JBrowse link
G DNMT3B DNA methyltransferase 3 beta ISO associated with Uterine Cervical Neoplasms; RGD PMID:22330137 RGD:9589117 NCBI chr24:22,096,386...22,123,378
Ensembl chr24:22,096,349...22,122,900 		JBrowse link
G DPYD dihydropyrimidine dehydrogenase treatment ISO CTD Direct Evidence: marker/mechanism
associated with Colonic Neoplasms		 CTD
RGD		 PMID:11383214 PMID:17611699 RGD:11251755 NCBI chr 6:51,789,786...52,564,802
Ensembl chr 6:51,814,573...52,580,923 		JBrowse link
G E2F8 E2F transcription factor 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27683099 NCBI chr21:41,340,410...41,358,261
Ensembl chr21:41,340,969...41,357,206 		JBrowse link
G EDN1 endothelin 1 ISO RGD PMID:12941866 RGD:734914 NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383 		JBrowse link
G EDNRA endothelin receptor type A ISO associated with Bladder Neoplasms RGD PMID:21183790 RGD:4892282 NCBI chr15:45,823,472...45,878,527
Ensembl chr15:45,823,560...45,876,463 		JBrowse link
G EEF1B2 eukaryotic translation elongation factor 1 beta 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 PMID:20562527 NCBI chr37:14,713,927...14,716,894
Ensembl chr37:14,714,017...14,716,850 		JBrowse link
G EEF2 eukaryotic translation elongation factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr20:55,577,413...55,586,422
Ensembl chr20:55,522,213...55,586,126 		JBrowse link
G EFNB2 ephrin B2 ISO associated with cholangiocarcinoma;protein:increased expression:biliary ductule (human) RGD PMID:25012246 RGD:153305948 NCBI chr22:55,567,992...55,609,210
Ensembl chr22:55,566,039...55,609,443 		JBrowse link
G EGF epidermal growth factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:21942447 PMID:23064031 NCBI chr32:30,073,541...30,166,904
Ensembl chr32:30,073,950...30,166,295 		JBrowse link
G EGFR epidermal growth factor receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:17369752 PMID:17575224 PMID:23867902 NCBI chr18:5,983,669...6,044,092
Ensembl chr18:5,982,770...6,042,631 		JBrowse link
G EHMT2 euchromatic histone lysine methyltransferase 2 ISO associated with lung neoplasms;
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:20940408 PMID:25115793 RGD:9589170 NCBI chr12:1,341,202...1,354,602
Ensembl chr12:1,341,191...1,354,584 		JBrowse link
G EIF1AX eukaryotic translation initiation factor 1A X-linked ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr  X:16,081,335...16,102,627
Ensembl chr  X:16,081,392...16,099,142 		JBrowse link
G EIF4A2 eukaryotic translation initiation factor 4A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr34:19,354,739...19,361,021
Ensembl chr34:19,354,825...19,409,844 		JBrowse link
G ELP3 elongator acetyltransferase complex subunit 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr25:29,415,229...29,507,159
Ensembl chr25:29,415,924...29,507,098 		JBrowse link
G EML4 EMAP like 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22986231 PMID:22999080 NCBI chr17:33,774,478...33,935,478
Ensembl chr17:33,774,140...33,934,147 		JBrowse link
G ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26037280 NCBI chr13:18,586,886...18,697,339
Ensembl chr13:18,587,129...18,697,324 		JBrowse link
G EPCAM epithelial cell adhesion molecule ISO RGD PMID:23390083 RGD:9685143 NCBI chr10:49,446,165...49,498,690
Ensembl chr10:49,485,746...49,498,475 		JBrowse link
G EPO erythropoietin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16699298 NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144 		JBrowse link
G EPOR erythropoietin receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:16699298 NCBI chr20:49,945,777...49,950,856
Ensembl chr20:49,945,777...49,950,856 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism
rat gene in a mouse model		 CTD
RGD		 PMID:11238891 PMID:16984552 RGD:734938 NCBI chr 9:22,760,373...22,785,367
Ensembl chr 9:22,759,256...22,785,294 		JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 disease_progression ISO CTD Direct Evidence: marker/mechanism
associated with lung adenocarcinoma
associated with Prostatic Neoplasms;protein:increased expression, altered localization:bone, nucleus
associated with Prostatic Neoplasms;protein:alternative form		 CTD
RGD		 PMID:17634423 PMID:18559590 PMID:26254096 PMID:28114269 RGD:126790470 RGD:2289944 RGD:2298500 NCBI chr10:406,856...424,746
Ensembl chr10:406,633...424,264 		JBrowse link
G ERBB4 erb-b2 receptor tyrosine kinase 4 disease_progression ISO associated with lung adenocarcinoma RGD PMID:26254096 RGD:126790470 NCBI chr37:19,029,647...20,134,576
Ensembl chr37:19,037,217...20,134,426 		JBrowse link
G ERCC1 ERCC excision repair 1, endonuclease non-catalytic subunit disease_progression ISO CTD Direct Evidence: marker/mechanism
associated with Melanoma		 CTD
RGD		 PMID:20801905 PMID:26202595 RGD:11252177 NCBI chr 1:110,130,353...110,146,660
Ensembl chr 1:110,130,481...110,146,602 		JBrowse link
G ERCC4 ERCC excision repair 4, endonuclease catalytic subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:20372803 NCBI chr 6:29,193,192...29,226,935
Ensembl chr 6:29,196,421...29,226,887 		JBrowse link
G ERP29 endoplasmic reticulum protein 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr26:9,608,352...9,616,711
Ensembl chr26:9,608,399...9,616,338 		JBrowse link
G ESR1 estrogen receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20104649 PMID:35044086 NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544 		JBrowse link
G ETV4 ETS variant transcription factor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27869830 NCBI chr 9:19,715,259...19,731,085
Ensembl chr 9:19,715,535...19,730,456 		JBrowse link
G EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit ISO associated with osteosarcoma
associated with lung non-small cell carcinoma
associated with stomach cancer;protein:increased expression:stomach		 RGD PMID:20132185 PMID:24097870 PMID:26265454 RGD:11532507 RGD:126779607 RGD:126781716 NCBI chr16:1,926,443...1,991,995
Ensembl chr16:1,925,956...1,991,838 		JBrowse link
G EZR ezrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:27137931 NCBI chr 1:48,160,206...48,210,036
Ensembl chr 1:48,160,206...48,210,036 		JBrowse link
G F2 coagulation factor II, thrombin ISO associated with Carcinoma, Small cell;protein:increased expression:brain RGD PMID:22065054 RGD:6893520 NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459 		JBrowse link
G FADD Fas associated via death domain ISO CTD Direct Evidence: marker/mechanism CTD PMID:16450001 NCBI chr18:48,087,447...48,094,497 JBrowse link
G FAS Fas cell surface death receptor ISO associated with Breast Neoplasms;protein:decreased expression:breast
associated with Mammary Neoplasms;protein:decreased expression:lung		 RGD PMID:17352235 PMID:17918178 RGD:2290048 RGD:2290053 NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321 		JBrowse link
G FASLG Fas ligand ISO associated with Breast Neoplasms;protein:decreased expression:breast RGD PMID:17352235 RGD:2290053 NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224 		JBrowse link
G FGF13 fibroblast growth factor 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19917848 NCBI chr  X:108,658,113...109,156,096
Ensembl chr  X:108,658,941...109,156,594 		JBrowse link
G FGFR1 fibroblast growth factor receptor 1 ISO associated with prostate adenocarcinoma RGD PMID:23576558 RGD:13504748 NCBI chr16:27,029,902...27,080,514
Ensembl chr16:27,031,588...27,078,261 		JBrowse link
G FLT1 fms related receptor tyrosine kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21975929 NCBI chr25:11,231,958...11,410,379
Ensembl chr25:11,231,737...11,407,621 		JBrowse link
G FN1 fibronectin 1 treatment ISO associated with stomach cancer; human cells in mouse model RGD PMID:27431311 RGD:152995400 NCBI chr37:22,456,854...22,522,410
Ensembl chr37:22,420,428...22,523,123 		JBrowse link
G FSCN1 fascin actin-bundling protein 1 ISO associated with Pancreatic Neoplasms RGD PMID:15626919 RGD:2317788 NCBI chr 6:12,360,849...12,370,906
Ensembl chr 6:12,354,599...12,370,808 		JBrowse link
G FTL ferritin light chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr 1:107,418,457...107,419,923
Ensembl chr 1:107,418,458...107,419,923 		JBrowse link
G GAB2 GRB2 associated binding protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21996746 NCBI chr21:20,414,903...20,605,807
Ensembl chr21:20,277,507...20,606,736 		JBrowse link
G GDF15 growth differentiation factor 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23996089 NCBI chr20:44,633,131...44,636,842
Ensembl chr20:44,634,588...44,636,821 		JBrowse link
G GJB1 gap junction protein beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17978847 NCBI chr  X:55,565,995...55,575,332
Ensembl chr  X:55,573,808...55,574,659 		JBrowse link
G GP1BA glycoprotein Ib platelet subunit alpha ISO associated with Melanoma, Experimental RGD PMID:19727118 RGD:10450866 NCBI chr 5:31,681,605...31,683,261 JBrowse link
G GPCPD1 glycerophosphocholine phosphodiesterase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25482527 NCBI chr24:16,153,622...16,203,155
Ensembl chr24:16,148,035...16,220,757 		JBrowse link
G GPI glucose-6-phosphate isomerase ISO RGD PMID:20978190 RGD:11051956 NCBI chr 1:117,922,380...117,948,325
Ensembl chr 1:117,922,635...117,948,316 		JBrowse link
G GPX2 glutathione peroxidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23867582 NCBI chr 8:39,322,040...39,325,833
Ensembl chr 8:39,322,034...39,325,817 		JBrowse link
G HABP2 hyaluronan binding protein 2 treatment ISO associated with Thyroid Neoplasms RGD PMID:22715430 RGD:11353856 NCBI chr28:24,489,665...24,522,336
Ensembl chr28:24,489,773...24,522,263 		JBrowse link
G HAVCR2 hepatitis A virus cellular receptor 2 disease_progression ISO DNA:polymorphisms: : +4259T>G (human) RGD PMID:22472081 RGD:7245505 NCBI chr 4:53,018,990...53,032,035
Ensembl chr 4:53,012,234...53,033,393 		JBrowse link
G HDAC3 histone deacetylase 3 ISO associated with Anaphylaxis;
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:24619412 PMID:34973135 RGD:9590165 NCBI chr 2:36,583,283...36,598,121
Ensembl chr 2:36,583,283...36,597,682 		JBrowse link
G HGF hepatocyte growth factor ISO CTD Direct Evidence: marker/mechanism
associated with Melanoma;
associated with Mammary Neoplasms, Experimental;
associated with Pancreatic Neoplasms		 CTD
RGD		 PMID:10688652 PMID:11893931 PMID:16459153 PMID:25971889 RGD:2317904 RGD:8548538 RGD:8548625 NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263 		JBrowse link
G HPSE heparanase ISO CTD Direct Evidence: marker/mechanism CTD PMID:22240343 NCBI chr32:7,166,437...7,199,659
Ensembl chr32:7,167,856...7,199,665 		JBrowse link
G HRH2 histamine receptor H2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:6224980 NCBI chr 4:37,333,843...37,407,146
Ensembl chr 4:37,275,852...37,386,072 		JBrowse link
G HSP90AA1 heat shock protein 90 alpha family class A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr 8:70,091,203...70,096,107
Ensembl chr 8:70,092,217...70,095,243 		JBrowse link
G IBSP integrin binding sialoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:22407340 PMID:24980816 NCBI chr32:11,187,188...11,200,860
Ensembl chr32:11,187,160...11,200,846 		JBrowse link
G ICAM1 intercellular adhesion molecule 1 ISO associated with Pancreatic Neoplasms;protein:increased expression:serum
associated with Melanoma, Cutaneous Malignant		 RGD PMID:10465581 PMID:12923961 RGD:2325163 RGD:8547593 NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914 		JBrowse link
G ID1 inhibitor of DNA binding 1 ISO CTD Direct Evidence: therapeutic CTD PMID:24910342 NCBI chr24:21,094,339...21,096,276
Ensembl chr24:21,094,755...21,096,276 		JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: marker/mechanism
associated with Uveal Melanoma;protein:increased expression:serum:
associated with Pancreatic Neoplasms		 CTD
RGD		 PMID:18398872 PMID:19375852 PMID:23197685 RGD:2317643 RGD:8548834 NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794 		JBrowse link
G IGF1R insulin like growth factor 1 receptor ISO associated with Pancreatic Neoplasms RGD PMID:16575403 RGD:2317645 NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387 		JBrowse link
G IGF2 insulin like growth factor 2 ISO associated with Arthritis, Experimental; protein:increased expression:lung, bone, serum: RGD PMID:21859454 RGD:5510000 NCBI chr18:46,294,036...46,311,982
Ensembl chr18:46,294,019...46,311,982 		JBrowse link
G IKZF1 IKAROS family zinc finger 1 ISO associated with colorectal cancer;DNA:polymorphisms: RGD PMID:31320627 RGD:150540328 NCBI chr18:1,661,851...1,750,987
Ensembl chr18:1,661,690...1,770,768 		JBrowse link
G IL10 interleukin 10 ISO RGD PMID:16035616 RGD:1598627 NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057 		JBrowse link
G IL18 interleukin 18 ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:serum
associated with breast cancer;DNA:SNP:promoter:-137G>C (rs187238) (human)
associated with breast cancer;protein:increased expression:serum		 CTD
RGD		 PMID:11215816 PMID:12209760 PMID:12748951 PMID:19152241 RGD:4889862 RGD:8655866 RGD:8655899 NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348 		JBrowse link
G IL2 interleukin 2 treatment ISO associated with neuroblastoma.
CTD Direct Evidence: therapeutic
associated with melanoma
associated with melanoma;		 RGD
CTD		 PMID:8610104 PMID:8642346 PMID:9362156 PMID:17105418 RGD:14747043 RGD:14865005 RGD:8663438 NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394 		JBrowse link
G IL6 interleukin 6 treatment ISO associated with stomach cancer, human cells in mouse model
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:21937440 PMID:26101800 PMID:28186964 RGD:127229952 NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519 		JBrowse link
G ITGA6 integrin subunit alpha 6 ISO RGD PMID:13130099 RGD:1302259 NCBI chr36:16,777,363...16,858,725
Ensembl chr36:16,776,863...16,855,449 		JBrowse link
G ITGB1 integrin subunit beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23562787 NCBI chr 2:3,728,472...3,757,696
Ensembl chr 2:3,670,596...3,756,961 		JBrowse link
G ITGB3 integrin subunit beta 3 ISO mRNA, protein:increased expression:lung
associated with renal cell carcinoma;DNA:missense mutation:cds:p.L33P (human)		 RGD PMID:16831169 PMID:21107114 RGD:5037225 RGD:6907406 NCBI chr 9:9,179,667...9,231,061
Ensembl chr 9:9,182,562...9,231,451 		JBrowse link
G JAK2 Janus kinase 2 treatment ISO associated with stomach cancer, human cells in mouse model RGD PMID:28186964 RGD:127229952 NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997 		JBrowse link
G JUP junction plakoglobin ISO associated with Ovarian Neoplasms RGD PMID:15619205 RGD:2301746 NCBI chr 9:21,028,773...21,053,071
Ensembl chr 9:21,028,828...21,053,071 		JBrowse link
G KDM6A lysine demethylase 6A disease_progression ISO associated with lung adenocarcinoma;protein:increased expression:brain (human) RGD PMID:33291558 RGD:150429741 NCBI chr  X:38,745,854...38,964,029
Ensembl chr  X:38,745,854...38,959,842 		JBrowse link
G KDR kinase insert domain receptor ISO associated with Carcinoma, Renal Cell RGD PMID:17465216 RGD:2301757 NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042 		JBrowse link
G KIF2C kinesin family member 2C disease_progression ISO associated with colorectal cancer RGD PMID:18506187 RGD:27372891 NCBI chr15:15,558,024...15,579,371
Ensembl chr15:15,558,021...15,579,217 		JBrowse link
G KISS1 KiSS-1 metastasis suppressor ISO associated with Ovarian Neoplasms RGD PMID:16283480 RGD:2298668 NCBI chr38:768,333...774,328
Ensembl chr38:768,585...773,382 		JBrowse link
G KMT2B lysine methyltransferase 2B ISO associated with lung adenocarcinoma RGD PMID:33291558 RGD:150429741 NCBI chr 1:116,894,024...116,913,464
Ensembl chr 1:116,893,074...116,913,472 		JBrowse link
G KMT2D lysine methyltransferase 2D disease_progression ISO associated with colorectal cancer;DNA:mutations:: RGD PMID:27875625 RGD:155582219 NCBI chr27:5,516,866...5,556,303
Ensembl chr27:5,521,804...5,553,490 		JBrowse link
G KRAS KRAS proto-oncogene, GTPase treatment
disease_progression		 ISO associated with colorectal cancer; DNA:mutation:cds:
associated with stomach cancer; human cells in mouse model
associated with colorectal cancer;DNA:mutation: :
associated with Fibrosarcoma;mRNA,protein:decreased expression::
CTD Direct Evidence: marker/mechanism
associated with colorectal cancer;DNA:mutations: :		 RGD
CTD		 PMID:3552201 PMID:8635384 PMID:26210240 PMID:27264476 PMID:27431311 More... RGD:11086960 RGD:11570402 RGD:14398745 RGD:14398751 RGD:152995400 NCBI chr27:22,261,753...22,296,704
Ensembl chr27:22,257,941...22,293,369 		JBrowse link
G KRT14 keratin 14 ISO mRNA:decreased expression:epithelial cell RGD PMID:9876218 RGD:1600180 NCBI chr 9:21,190,672...21,195,060
Ensembl chr 9:21,156,045...21,265,564 		JBrowse link
G KRT20 keratin 20 ISO associated with Colorectal Neoplasms RGD PMID:10931219 RGD:2317676 NCBI chr 9:21,808,171...21,818,301
Ensembl chr 9:21,808,548...21,817,387 		JBrowse link
G L1CAM L1 cell adhesion molecule treatment ISO associated with Lung Neoplasms;
associated with Pancreatic Neoplasms;		 RGD PMID:22095073 PMID:22307136 RGD:11570404 RGD:11570503 NCBI chr  X:121,708,695...121,722,819
Ensembl chr  X:121,708,894...121,733,365 		JBrowse link
G LAMC2 laminin subunit gamma 2 ISO associated with lung adenocarcinoma; RGD PMID:25591736 RGD:11075980 NCBI chr 7:16,543,541...16,625,304
Ensembl chr 7:16,569,086...16,624,085 		JBrowse link
G LCN2 lipocalin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24570342 NCBI chr 9:55,328,118...55,342,535
Ensembl chr 9:55,328,133...55,332,038 		JBrowse link
G LECT2 leukocyte cell derived chemotaxin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr11:23,864,062...23,873,720
Ensembl chr11:23,864,064...23,886,226 		JBrowse link
G LEF1 lymphoid enhancer binding factor 1 ISO CTD Direct Evidence: marker/mechanism
associated with prostate cancer		 CTD
RGD		 PMID:27067790 PMID:27811057 RGD:11531513 NCBI chr32:28,516,002...28,633,759
Ensembl chr32:28,517,108...28,634,019 		JBrowse link
G LGALS3 galectin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25882088 NCBI chr 8:30,977,438...30,994,711
Ensembl chr 8:30,983,633...30,994,705 		JBrowse link
G LLGL2 LLGL scribble cell polarity complex component 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28114269 NCBI chr 9:4,975,309...5,008,383
Ensembl chr 9:4,975,660...4,996,775 		JBrowse link
G LOC100687127 thioredoxin-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:30396169 NCBI chr  X:82,986,288...82,986,753 JBrowse link
G LOC100855904 mucin-6 disease_progression ISO associated with cholangiocarcinoma RGD PMID:18410610 RGD:2325159 NCBI chr18:45,359,412...45,376,678 JBrowse link
G LOC100856339 phosphatidylinositol 3-kinase regulatory subunit gamma ISO associated with Adenocarcinoma, Colon RGD PMID:24837077 RGD:13432045 NCBI chr15:14,222,059...14,357,200
Ensembl chr15:14,235,824...14,353,832 		JBrowse link
G LOC102153034 calmodulin-like protein 3 ameliorates ISO associated with hepatocellular carcinoma; protein:decreased expression:liver (human)
associated with hepatocellular carcinoma; human cells in mouse model		 RGD PMID:29445139 RGD:151665319 NCBI chr 2:30,410,830...30,411,981 JBrowse link
G LOC403581 peptidylprolyl isomerase A (cyclophilin A) pseudogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:21956400 NCBI chr 7:80,937,433...80,938,175 JBrowse link
G LOC480600 chemokine (C-C motif) ligand 3 ISO RGD PMID:18941229 RGD:7241810 NCBI chr 9:37,708,561...37,710,209
Ensembl chr 9:37,676,966...37,710,209 		JBrowse link
G LOC482182 sulfotransferase 1E1 ISO associated with Colonic Neoplasms;protein:increased expression:liver RGD PMID:16895976 RGD:2302565 NCBI chr13:59,323,430...59,343,745 JBrowse link
G LOC607874 cystatin-C-like ISO protein:decreased expression:cerebrospinal fluid RGD PMID:12589965 RGD:5686394 NCBI chr23:49,562...53,618 JBrowse link
G LY96 lymphocyte antigen 96 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22180778 NCBI chr29:22,493,757...22,515,147
Ensembl chr29:22,493,896...22,515,117 		JBrowse link
G MACC1 MET transcriptional regulator MACC1 treatment ISO associated with stomach cancer; human cells in mouse model
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:27431311 PMID:36008464 RGD:152995400 NCBI chr14:34,189,983...34,271,998
Ensembl chr14:34,075,463...34,251,330 		JBrowse link
G MAP2K4 mitogen-activated protein kinase kinase 4 disease_progression ISO associated with oral squamous cell carcinoma;mRNA, protein:increased expression:lymph node (human) RGD PMID:22165133 RGD:150429749 NCBI chr 5:36,142,610...36,243,673
Ensembl chr 5:36,118,388...36,241,296 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 treatment ISO CTD Direct Evidence: marker/mechanism
associated with prostate adenocarcinoma		 CTD
RGD		 PMID:22139534 PMID:22580338 RGD:13504820 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22580338 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425 		JBrowse link
G MAPK9 mitogen-activated protein kinase 9 ISO CTD Direct Evidence: therapeutic
associated with Colorectal Neoplasms		 CTD
RGD		 PMID:21779479 PMID:25205654 RGD:13217416 NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119 		JBrowse link
G MED28 mediator complex subunit 28 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21942447 NCBI chr 3:62,887,095...62,895,588
Ensembl chr 3:62,890,515...62,895,562 		JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase disease_progression ISO associated with Squamous Cell Carcinoma of the Tongue;
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:20080979 PMID:21225626 PMID:22704061 RGD:8548616 NCBI chr14:55,599,047...55,711,626
Ensembl chr14:55,598,337...55,724,027 		JBrowse link
G MIR125A microRNA mir-125a ISO CTD Direct Evidence: marker/mechanism
associated with stomach cancer;		 CTD
RGD		 PMID:19487542 PMID:30117667 RGD:21403678 NCBI chr 1:105,400,273...105,400,332
Ensembl chr 1:105,400,270...105,400,337 		JBrowse link
G MIR130A microRNA mir-130a ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr18:38,543,618...38,543,679
Ensembl chr18:38,543,618...38,543,681 		JBrowse link
G MIR136 microRNA mir-136 ameliorates ISO associated with stomach cancer;human cells in mouse model RGD PMID:28656883 RGD:153344628 NCBI chr 8:69,106,615...69,106,670
Ensembl chr 8:69,106,598...69,106,687 		JBrowse link
G MIR148B microRNA mir-148b ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr27:975,146...975,206
Ensembl chr27:975,131...975,220 		JBrowse link
G MIR152 microRNA mir-152 ISO associated with Castration-Resistant Prostatic Neoplasms RGD PMID:23574937 RGD:19165145 NCBI chr 9:24,335,161...24,335,219
Ensembl chr 9:24,335,146...24,335,225 		JBrowse link
G MIR155 microRNA mir-155 ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:19487542 PMID:27692344 PMID:27856635 RGD:21079446 NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833 		JBrowse link
G MIR181C microRNA mir-181c ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr20:48,593,343...48,593,403
Ensembl chr20:48,593,325...48,593,421 		JBrowse link
G MIR193A microRNA mir-193a exacerbates ISO associated with colorectal cancer; miRNA:decreased expression:colorectum (human)
associated with lung non-small cell carcinoma; human cells in mouse model		 RGD PMID:24469061 PMID:25232258 PMID:30685413 RGD:153344566 RGD:153344592 RGD:153344599 NCBI chr 9:41,316,481...41,316,536
Ensembl chr 9:41,316,474...41,316,542 		JBrowse link
G MIR197 microRNA mir-197 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 6:42,271,719...42,271,779
Ensembl chr 6:42,271,708...42,271,797 		JBrowse link
G MIR19A microRNA mir-19a ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr22:42,478,298...42,478,355
Ensembl chr22:42,478,285...42,478,366 		JBrowse link
G MIR205 microRNA mir-205 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 7:8,090,511...8,090,579
Ensembl chr 7:8,090,511...8,090,579 		JBrowse link
G MIR20A microRNA mir-20a ISO associated with colorectal cancer RGD PMID:27286257 RGD:25823157 NCBI chr22:42,478,462...42,478,520
Ensembl chr22:42,478,462...42,478,520 		JBrowse link
G MIR20B microRNA mir-20b ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr  X:104,896,091...104,896,158
Ensembl chr  X:104,896,091...104,896,158 		JBrowse link
G MIR21 microRNA mir-21 treatment
ameliorates		 ISO associated with prostate carcinoma; human cells in mouse model
CTD Direct Evidence: marker/mechanism
human cells in mouse model;associated with breast cancer		 RGD
CTD		 PMID:18270520 PMID:26101800 PMID:32736696 RGD:152998873 RGD:152998897 NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624 		JBrowse link
G MIR221 microRNA mir-221 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr  X:39,523,890...39,523,951
Ensembl chr  X:39,523,885...39,523,954 		JBrowse link
G MIR222 microRNA mir-222 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr  X:39,524,519...39,524,608
Ensembl chr  X:39,524,519...39,524,608 		JBrowse link
G MIR224 microRNA mir-224 ISO CTD Direct Evidence: marker/mechanism
associated with colorectal cancer; mRNA:increased expression:colorectal mucosa:		 CTD
RGD		 PMID:19487542 PMID:25919696 RGD:14398749 NCBI chr  X:119,925,345...119,925,413
Ensembl chr  X:119,925,345...119,925,413 		JBrowse link
G MIR30A microRNA mir-30a ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr12:33,783,894...33,783,956
Ensembl chr12:33,783,891...33,783,961 		JBrowse link
G MIR30E microRNA mir-30e ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr15:2,283,306...2,283,369
Ensembl chr15:2,283,306...2,283,369 		JBrowse link
G MIR31 microRNA mir-31 disease_progression
treatment		 ISO CTD Direct Evidence: marker/mechanism
associated with colorectal cancer;RNA:increased expression:colorectum (human)
associated with stomach cancer;human cells in mouse model		 CTD
RGD		 PMID:19487542 PMID:26497852 PMID:27174918 PMID:30108104 RGD:153297776 RGD:153297806 RGD:153297811 NCBI chr11:40,904,438...40,904,496
Ensembl chr11:40,904,437...40,904,503 		JBrowse link
G MIR335 microRNA mir-335 ISO lung metastasis RGD PMID:21822301 RGD:14394425 NCBI chr14:6,444,861...6,444,918
Ensembl chr14:6,444,847...6,444,932 		JBrowse link
G MIR342 microRNA mir-342 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 8:68,424,656...68,424,718 JBrowse link
G MIR346 microRNA mir-346 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27501413 PMID:27777383 NCBI chr 4:34,073,335...34,073,429
Ensembl chr 4:34,073,335...34,073,429 		JBrowse link
G MIR34B microRNA mir-34b ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 5:21,558,685...21,558,768
Ensembl chr 5:21,558,685...21,558,768 		JBrowse link
G MIR34C microRNA mir-34c ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 5:21,558,106...21,558,160 JBrowse link
G MIR370 microRNA mir-370 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 8:69,132,786...69,132,864
Ensembl chr 8:69,132,786...69,132,864 		JBrowse link
G MIR494 microRNA mir-494 ISO associated with osteosarcoma; RNA:decreased expression:bone, serum RGD PMID:30314946 PMID:35117781 RGD:156420141 RGD:156430319 NCBI chr 8:69,261,385...69,261,465
Ensembl chr 8:69,261,385...69,261,465 		JBrowse link
G MIR532 microRNA mir-532 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr  X:42,774,680...42,774,738
Ensembl chr  X:42,774,680...42,774,738 		JBrowse link
G MIR885 microRNA mir-885 ISO CTD Direct Evidence: therapeutic CTD PMID:27738331 NCBI chr20:7,968,529...7,968,602
Ensembl chr20:7,968,529...7,968,602 		JBrowse link
G MIR96 microRNA mir-96 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr14:7,068,754...7,068,842
Ensembl chr14:7,068,754...7,068,842 		JBrowse link
G MIR99A-1 microRNA mir-99a-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr31:13,258,782...13,258,840
Ensembl chr31:13,258,782...13,258,840 		JBrowse link
G MIR99A-2 microRNA mir-99a-2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 5:12,047,369...12,047,425
Ensembl chr 5:12,047,369...12,047,425 		JBrowse link
G MIR99B microRNA mir-99b ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 1:105,400,925...105,400,984
Ensembl chr 1:105,400,925...105,400,984 		JBrowse link
G MKI67 marker of proliferation Ki-67 ISO associated with Pancreatic Neoplasms RGD PMID:20388395 RGD:2317702 NCBI chr28:36,920,679...36,939,336
Ensembl chr28:36,913,023...36,939,486 		JBrowse link
G MLH1 mutL homolog 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17717427 NCBI chr23:6,889,108...6,938,117
Ensembl chr23:6,889,135...6,938,116 		JBrowse link
G MMP1 matrix metallopeptidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12538496 PMID:19487542 PMID:22580338 PMID:23548910 NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648 		JBrowse link
G MMP13 matrix metallopeptidase 13 ISO associated with Carcinoma, Renal Cell;mRNA, protein:increased expression:bone RGD PMID:18709334 RGD:2306080 NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121 		JBrowse link
G MMP2 matrix metallopeptidase 2 disease_progression ISO associated with Gallbladder Neoplasms; protein:increased expression:gallbladder
associated with pancreatic cancer; protein:increased expression, increased activity:pancreas
associated with Mammary Neoplasms, Animal;protein:increased expression:brain
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:12173379 PMID:16158251 PMID:16475674 PMID:18398872 PMID:18665467 More... RGD:2325743 RGD:2325749 RGD:8547884 NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113 		JBrowse link
G MMP24 matrix metallopeptidase 24 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27869830 NCBI chr24:24,223,049...24,258,082
Ensembl chr24:24,232,833...24,255,725 		JBrowse link
G MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) ISO associated with Mammary Neoplasms, Animal;protein:increased expression:brain RGD PMID:16158251 RGD:8547884 NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222 		JBrowse link
G MMP9 matrix metallopeptidase 9 severity
disease_progression		 ISO associated with Mammary Neoplasms, Animal; associated with Arthritis, Experimental
CTD Direct Evidence: marker/mechanism
associated with osteosarcoma;protein:increased expression:bone (human)
associated with skin melanoma;DNA:missense mutation:cds:p.Q279R (human)
associated with Melanoma
associated with Mammary Neoplasms, Animal;protein:increased expression:brain
associated with carcinoma, pancreatic ductal; protein:increased expression:pancreas
associated with pancreatic cancer; protein:increased expression, increased activity:pancreas		 RGD
CTD		 PMID:8912869 PMID:12173379 PMID:15659795 PMID:16033831 PMID:16158251 More... RGD:152023746 RGD:2325749 RGD:2325855 RGD:5510000 RGD:8547861 RGD:8547878 RGD:8547884 RGD:8547886 RGD:8547928 NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293 		JBrowse link
G MSH2 mutS homolog 2 ISO associated with Breast Neoplasms RGD PMID:17390069 RGD:2293506 NCBI chr10:49,517,448...49,594,001
Ensembl chr10:49,517,369...49,594,210 		JBrowse link
G MST1 macrophage stimulating 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28114269 NCBI chr20:39,582,237...39,586,958
Ensembl chr20:39,582,282...39,586,908 		JBrowse link
G MTDH metadherin ISO CTD Direct Evidence: therapeutic CTD PMID:19111877 NCBI chr29:41,675,601...41,732,389
Ensembl chr29:41,640,035...41,729,949 		JBrowse link
G MTHFR methylenetetrahydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:17704422 NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818 		JBrowse link
G MTOR mechanistic target of rapamycin kinase ISO associated with Pancreatic Neoplasms RGD PMID:23149918 RGD:10040959 NCBI chr 2:84,818,893...84,939,283
Ensembl chr 2:84,787,708...84,939,114 		JBrowse link
G MUC1 mucin 1, cell surface associated disease_progression ISO associated with Pancreatic Neoplasms
associated with Carcinoma, Renal Cell;		 RGD PMID:10390012 PMID:12941828 PMID:16707592 RGD:2324648 RGD:2324652 RGD:7245968 NCBI chr 7:42,338,939...42,344,690
Ensembl chr 7:42,340,375...42,344,690 		JBrowse link
G MUC4 mucin 4, cell surface associated ISO associated with Melanoma RGD PMID:10918186 RGD:2303746 NCBI chr33:29,061,372...29,084,938
Ensembl chr33:29,063,096...29,111,802 		JBrowse link
G MUC5AC mucin 5AC, oligomeric mucus/gel-forming ISO associated with chloangiocarcinoma;protein:increased expression:bile duct RGD PMID:16124042 RGD:2324987 NCBI chr18:45,471,232...45,498,961 JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:22321834 NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309 		JBrowse link
G MYLK myosin light chain kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12970723 PMID:18710790 NCBI chr33:26,663,991...26,867,370
Ensembl chr33:26,664,800...26,843,181 		JBrowse link
G NAGK N-acetylglucosamine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr17:51,367,477...51,376,461 JBrowse link
G NCOA1 nuclear receptor coactivator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21080969 NCBI chr17:18,880,676...19,124,300
Ensembl chr17:18,880,383...19,122,258 		JBrowse link
G NDC80 NDC80 kinetochore complex component disease_progression ISO associated with melanoma RGD PMID:31173190 RGD:40822820 NCBI chr 7:69,268,218...69,317,126
Ensembl chr 7:69,268,242...69,317,072 		JBrowse link
G NDRG1 N-myc downstream regulated 1 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:15867226 PMID:22972152 NCBI chr13:29,689,294...29,745,964
Ensembl chr13:29,650,444...29,746,382 		JBrowse link
G NECAB3 N-terminal EF-hand calcium binding protein 3 severity ISO protein:increased expression:bone (human) RGD PMID:29039472 RGD:151347601 NCBI chr24:22,895,149...22,904,689
Ensembl chr24:22,878,402...22,904,656 		JBrowse link
G NECTIN2 nectin cell adhesion molecule 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29321541 NCBI chr 1:110,543,140...110,569,168
Ensembl chr 1:110,543,247...110,569,143 		JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32682831 NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524 		JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 ISO associated with prostate cancer RGD PMID:17974971 RGD:13506764 NCBI chr32:23,948,598...24,040,704
Ensembl chr32:23,942,954...24,040,703 		JBrowse link
G NFKBIA NFKB inhibitor alpha ISO associated with prostate cancer;protein:increased serine phosphorylation RGD PMID:23093296 RGD:13506767 NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433 		JBrowse link
G NME1 non-metastatic cells 1, protein (NM23A) expressed in ISO CTD Direct Evidence: marker/mechanism
associated with Ovarian Neoplasms		 CTD
RGD		 PMID:7622307 PMID:15928304 RGD:2299069 NCBI chr 9:26,990,336...26,998,895
Ensembl chr 9:26,990,469...26,998,955 		JBrowse link
G NME2 non-metastatic cells 2, protein (NM23B) expressed in resistance ISO RGD PMID:8621239 RGD:2299081 NCBI chr 9:27,002,114...27,005,740
Ensembl chr 9:27,001,733...27,015,934 		JBrowse link
G NOS2 nitric oxide synthase 2 disease_progression ISO associated with Carcinoma, Pancreatic Ductal; protein:increased expression:pancreas
associated with Gallbladder Neoplasms: protein:increased expression:gallbladder		 RGD PMID:12660813 PMID:14991947 PMID:15222037 RGD:2325242 RGD:2325250 RGD:2325254 NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588 		JBrowse link
G NOS3 nitric oxide synthase 3 susceptibility ISO protein:increased expression:blood vessel endothelial cell
associated with Prostatic Neoplasms;DNA:polymorphism
associated with Breast Neoplasms;DNA:polymorphism:promoter:-786T>C (human)		 RGD PMID:12445681 PMID:14623178 PMID:14672505 RGD:2292080 RGD:2292081 RGD:2292087 NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277 		JBrowse link
G NPPA natriuretic peptide A ISO CTD Direct Evidence: therapeutic CTD PMID:18717826 NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385 		JBrowse link
G NSUN6 NOP2/Sun RNA methyltransferase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28114269 NCBI chr 2:18,477,150...18,534,716
Ensembl chr 2:18,477,211...18,534,710 		JBrowse link
G OGN osteoglycin ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr 1:98,939,374...98,959,173
Ensembl chr 1:98,939,429...98,957,543 		JBrowse link
G OLIG2 oligodendrocyte transcription factor 2 ISO associated with breast cancer RGD PMID:27340107 RGD:40902824 NCBI chr31:27,674,112...27,677,521
Ensembl chr31:27,674,107...27,676,822 		JBrowse link
G ORAI1 ORAI calcium release-activated calcium modulator 1 treatment ISO associated with stomach cancer; human cells in mouse model RGD PMID:27431311 RGD:152995400 NCBI chr26:7,584,276...7,599,667
Ensembl chr26:7,584,880...7,599,401 		JBrowse link
G OSM oncostatin M ISO CTD Direct Evidence: marker/mechanism CTD PMID:21937440 NCBI chr26:23,421,787...23,439,332
Ensembl chr26:23,421,787...23,426,036 		JBrowse link
G PCNA proliferating cell nuclear antigen ISO associated with Seminoma RGD PMID:9143022 RGD:2315011 NCBI chr24:16,478,774...16,485,992
Ensembl chr24:16,478,769...16,484,992 		JBrowse link
G PDE5A phosphodiesterase 5A ISO CTD Direct Evidence: marker/mechanism CTD PMID:12972520 NCBI chr32:38,272,573...38,407,517
Ensembl chr32:38,244,338...38,407,522 		JBrowse link
G PDGFB platelet derived growth factor subunit B ISO associated with Breast Neoplasms;mRNA, protein:increased expression:breast RGD PMID:16596190 RGD:2292179 NCBI chr10:25,798,877...25,819,422
Ensembl chr10:25,798,938...25,817,746 		JBrowse link
G PDGFRB platelet derived growth factor receptor beta ISO mRNA,protein:increased expression: :
associated with Carcinoma, Renal Cell		 RGD PMID:14593398 PMID:15994946 RGD:13703041 RGD:2292198 NCBI chr 4:58,925,922...58,963,639
Ensembl chr 4:58,926,351...58,962,283 		JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 ISO associated with Prostatic Neoplasms;protein:decreased expression: RGD PMID:12813171 RGD:2302862 NCBI chr26:14,522,124...14,526,370
Ensembl chr26:14,500,074...14,529,354 		JBrowse link
G PIK3C2B phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:21986133 NCBI chr38:974,248...1,016,226
Ensembl chr38:975,749...1,027,679 		JBrowse link
G PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha treatment ISO associated with colorectal cancer;DNA:mutations::
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:23302486 PMID:29106415 RGD:14402409 NCBI chr34:12,600,140...12,681,905
Ensembl chr34:12,600,233...12,675,910 		JBrowse link
G PLAU plasminogen activator, urokinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16475674 NCBI chr 4:24,329,139...24,333,893
Ensembl chr 4:24,328,925...24,334,851 		JBrowse link
G PLAUR plasminogen activator, urokinase receptor ISO associated with Ovarian Neoplasms
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:15659795 PMID:22577342 RGD:6483788 NCBI chr 1:111,476,804...111,490,876
Ensembl chr 1:111,476,893...111,490,880 		JBrowse link
G PLOD2 procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 ameliorates ISO associated with lung non-small cell carcinoma RGD PMID:29072684 RGD:151665822 NCBI chr23:41,290,183...41,382,917
Ensembl chr23:41,290,567...41,382,807 		JBrowse link
G PML PML nuclear body scaffold ISO CTD Direct Evidence: marker/mechanism CTD PMID:29335545 NCBI chr30:37,232,337...37,278,434
Ensembl chr30:37,232,306...37,277,741 		JBrowse link
G PMS2 PMS1 homolog 2, mismatch repair system component ISO CTD Direct Evidence: marker/mechanism CTD PMID:17717427 NCBI chr 6:11,411,062...11,438,767
Ensembl chr 6:11,349,453...11,438,940 		JBrowse link
G PRNP prion protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:17387271 NCBI chr24:16,845,224...16,862,319
Ensembl chr24:16,846,207...16,859,815 		JBrowse link
G PROX1 prospero homeobox 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17415710 NCBI chr 7:11,996,282...12,047,693
Ensembl chr 7:11,996,703...12,044,036 		JBrowse link
G PRSS8 serine protease 8 ISO associated with Prostatic Neoplasms;mRNA:decreased expression:prostate gland, bone RGD PMID:12518323 RGD:2292484 NCBI chr 6:17,110,251...17,114,564
Ensembl chr 6:17,110,300...17,114,816 		JBrowse link
G PTCH1 patched 1 ISO associated with colorectal cancer RGD PMID:20230186 RGD:150523835 NCBI chr 1:71,246,750...71,309,036
Ensembl chr 1:71,238,195...71,305,662 		JBrowse link
G PTEN phosphatase and tensin homolog ISO CTD Direct Evidence: marker/mechanism
associated with Mammary Neoplasms, Experimental		 CTD
RGD		 PMID:10978354 PMID:18381417 RGD:2292496 NCBI chr26:37,853,148...37,913,176
Ensembl chr26:37,835,661...37,913,176 		JBrowse link
G PTGIS prostaglandin I2 synthase exacerbates ISO associated with colorectal cancer; protein:increased expression:colorectum (human) RGD PMID:22109564 RGD:151347833 NCBI chr24:36,129,091...36,162,525
Ensembl chr24:36,132,173...36,162,509 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO associated with Mammary Neoplasms, Experimental
associated with lung neoplasm
associated with Breast Neoplasms
CTD Direct Evidence: marker/mechanism
associated with osteosarcoma;
associated with breast neoplasm;		 RGD
CTD		 PMID:16489006 PMID:18398660 PMID:18509974 PMID:18663571 PMID:18797196 More... RGD:2300119 RGD:2300249 RGD:5135282 RGD:5135498 RGD:5135500 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903 		JBrowse link
G PTK2 protein tyrosine kinase 2 ISO associated with Mammary Neoplasms, Experimental RGD PMID:15930288 PMID:16547501 RGD:2292557 RGD:2292560 NCBI chr13:35,302,439...35,541,336
Ensembl chr13:35,303,380...35,541,294 		JBrowse link
G PXN paxillin ISO CTD Direct Evidence: marker/mechanism CTD PMID:18492274 NCBI chr26:16,157,231...16,224,028
Ensembl chr26:16,159,025...16,184,820 		JBrowse link
G RAC1 Rac family small GTPase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18506888 NCBI chr 6:11,726,259...11,758,532
Ensembl chr 6:11,655,494...11,757,216 		JBrowse link
G RAD52 RAD52 homolog, DNA repair protein susceptibility ISO associated with colorectal cancer; DNA:SNP:3'utr: (rs7963551) (human) RGD PMID:29245274 RGD:151361161 NCBI chr27:42,915,334...43,032,293
Ensembl chr27:42,915,634...42,951,323 		JBrowse link
G RAMP2 receptor activity modifying protein 2 ISO RGD PMID:31754214 RGD:152985691 NCBI chr 9:20,250,711...20,252,485 JBrowse link
G RB1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27137931 NCBI chr22:3,061,621...3,204,625
Ensembl chr22:3,063,239...3,257,726 		JBrowse link
G RECK reversion inducing cysteine rich protein with kazal motifs ISO CTD Direct Evidence: marker/mechanism CTD PMID:17233834 NCBI chr11:52,519,303...52,607,753
Ensembl chr11:52,519,317...52,607,217 		JBrowse link
G RHOA ras homolog family member A ISO associated with Ovarian Neoplasms RGD PMID:12808121 RGD:2298873 NCBI chr20:39,824,552...39,888,089
Ensembl chr20:39,824,575...39,887,215 		JBrowse link
G RHOC ras homolog family member C ISO CTD Direct Evidence: marker/mechanism
associated with Ovarian Neoplasms		 CTD
RGD		 PMID:12808121 PMID:18230616 RGD:2298873 NCBI chr17:62,868,373...62,872,322 JBrowse link
G RIT1 Ras like without CAAX 1 ameliorates ISO associated with esophagus squamous cell carcinoma; human cells in mouse model RGD PMID:30348939 RGD:152999018 NCBI chr 7:41,894,726...41,903,450
Ensembl chr 7:41,895,330...41,901,173 		JBrowse link
G ROR1 receptor tyrosine kinase like orphan receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28114269 NCBI chr 5:46,010,097...46,477,882
Ensembl chr 5:46,013,195...46,190,880 		JBrowse link
G RPS6KA3 ribosomal protein S6 kinase A3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21488662 NCBI chr  X:15,991,623...16,079,689
Ensembl chr  X:15,998,172...16,074,749 		JBrowse link
G RXRA retinoid X receptor alpha ISO associated with Prostatic Neoplasms RGD PMID:15318950 RGD:1643115 NCBI chr 9:50,525,195...50,575,720
Ensembl chr 9:50,484,567...50,573,119 		JBrowse link
G S100A4 S100 calcium binding protein A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21636539 PMID:21685359 PMID:36008464 NCBI chr 7:43,494,007...43,496,021 JBrowse link
G SERPINA1 serpin family A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr 8:63,388,498...63,400,377
Ensembl chr 8:63,376,945...63,398,435 		JBrowse link
G SERPINB5 serpin family B member 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19514085 NCBI chr 1:13,566,982...13,638,839
Ensembl chr 1:13,568,376...13,638,781 		JBrowse link
G SERPINC1 serpin family C member 1 treatment ISO associated with Adenocarcinoma, Colon
associated with Melanoma		 RGD PMID:16440418 RGD:1599327 NCBI chr 7:25,322,668...25,333,022
Ensembl chr 7:25,316,129...25,332,987 		JBrowse link
G SERPINF1 serpin family F member 1 ISO associated with Prostatic Neoplasms RGD PMID:15313905 RGD:2312355 NCBI chr 9:45,891,368...45,902,768
Ensembl chr 9:45,891,410...45,902,765 		JBrowse link
G SIRT1 sirtuin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27793039 NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279 		JBrowse link
G SIX1 SIX homeobox 1 ISO human gene in a mouse model RGD PMID:23435380 RGD:11561950 NCBI chr 8:35,676,705...35,679,534
Ensembl chr 8:35,676,479...35,679,534 		JBrowse link
G SLC39A4 solute carrier family 39 member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20957146 NCBI chr13:37,833,073...37,838,304
Ensembl chr13:37,833,156...37,838,522 		JBrowse link
G SLC39A6 solute carrier family 39 member 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12839489 NCBI chr 7:54,059,193...54,080,582
Ensembl chr 7:54,059,193...54,080,582 		JBrowse link
G SLC3A2 solute carrier family 3 member 2 ISO RGD PMID:19018776 RGD:151361278 NCBI chr18:53,810,468...53,819,021
Ensembl chr18:53,810,398...53,819,021 		JBrowse link
G SLC7A11 solute carrier family 7 member 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19015640 NCBI chr19:4,289,792...4,379,060
Ensembl chr19:4,289,850...4,389,048 		JBrowse link
G SLC7A5 solute carrier family 7 member 5 ISO RGD PMID:19018776 RGD:151361278 NCBI chr 5:65,313,105...65,343,858
Ensembl chr 5:65,313,105...65,343,858 		JBrowse link
G SLCO1B2 solute carrier organic anion transporter family member 1B2 ISO associated with Colonic Neoplasms;protein:decreased expression:liver RGD PMID:16895976 RGD:2302565 NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989 		JBrowse link
G SMAD4 SMAD family member 4 disease_progression ISO associated with colorectal carcinoma;DNA:mutation:cds: RGD PMID:10340381 RGD:21066333 NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405 		JBrowse link
G SMO smoothened, frizzled class receptor ISO associated with colon cancer RGD PMID:23098507 RGD:150340555 NCBI chr14:7,518,871...7,527,703
Ensembl chr14:7,518,856...7,528,033 		JBrowse link
G SNAI1 snail family transcriptional repressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22580338 PMID:23219715 NCBI chr24:36,498,343...36,503,623
Ensembl chr24:36,498,062...36,503,628 		JBrowse link
G SNAI2 snail family transcriptional repressor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22580338 NCBI chr29:1,154,132...1,156,653
Ensembl chr29:1,154,036...1,156,653 		JBrowse link
G SNCG synuclein gamma ISO protein:increased expression:breast
DNA:hypomethylation: :		 RGD PMID:16140929 PMID:16821081 RGD:6478795 RGD:6478797 NCBI chr 4:34,604,867...34,608,851
Ensembl chr 4:34,605,091...34,608,842 		JBrowse link
G SOD2 superoxide dismutase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12538496 PMID:18930813 PMID:19487542 PMID:22580338 NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706 		JBrowse link
G SOX30 SRY-box transcription factor 30 ISO associated with lung non-small cell carcinoma;mRNA, protein:decreased expression: : RGD PMID:29739711 RGD:151660333 NCBI chr 4:52,587,163...52,615,945
Ensembl chr 4:52,587,355...52,615,945 		JBrowse link
G SOX9 SRY-box transcription factor 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32682831 NCBI chr 9:8,275,049...8,278,172
Ensembl chr 9:8,275,049...8,278,172 		JBrowse link
G SP1 Sp1 transcription factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12538496 PMID:35072892 NCBI chr27:1,802,587...1,861,187
Ensembl chr27:1,805,184...1,847,226 		JBrowse link
G SPA17 sperm autoantigenic protein 17 ISO associated with ovarian carcinoma;proetin:increased expression:epithelium: RGD PMID:19744347 RGD:27226802 NCBI chr 5:9,719,222...9,731,521
Ensembl chr 5:9,719,241...9,730,913 		JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:16474180 PMID:22407340 RGD:1581330 NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase ISO associated with colorectal carcinoma;protein:increased activity:colorectum: RGD PMID:7687314 PMID:15486073 RGD:150521537 RGD:1581401 NCBI chr24:25,982,499...26,019,748
Ensembl chr24:25,999,048...26,018,077 		JBrowse link
G SREBF2 sterol regulatory element binding transcription factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30394316 NCBI chr10:23,451,923...23,532,765
Ensembl chr10:23,452,561...23,518,689
Ensembl chr10:23,452,561...23,518,689 		JBrowse link
G SRSF1 serine and arginine rich splicing factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr 9:32,692,517...32,696,325
Ensembl chr 9:32,694,073...32,696,285 		JBrowse link
G SRSF2 serine and arginine rich splicing factor 2 severity ISO associated with hepatocellular carcinoma RGD PMID:29278882 RGD:150429692 NCBI chr 9:4,028,414...4,032,371
Ensembl chr 9:4,028,482...4,030,793 		JBrowse link
G SRSF5 serine and arginine rich splicing factor 5 ISO associated with Ovarian Neoplasms;mRNA:increased expression:epithelium of female gonad (human) RGD PMID:23748175 RGD:11039469 NCBI chr 8:43,514,048...43,519,019
Ensembl chr 8:43,514,076...43,518,481 		JBrowse link
G SRSF6 serine and arginine rich splicing factor 6 ISO associated with Ovarian Neoplasms;mRNA:increased expression:epithelium of female gonad (human) RGD PMID:23748175 RGD:11039469 NCBI chr24:31,217,190...31,222,852
Ensembl chr24:31,217,184...31,218,618 		JBrowse link
G ST14 ST14 transmembrane serine protease matriptase ISO associated with Breast Neoplasms
associated with Prostatic Neoplasms		 RGD PMID:17456594 PMID:18813126 RGD:2315088 RGD:2315092 NCBI chr 5:4,652,493...4,666,728
Ensembl chr 5:4,651,863...4,691,069 		JBrowse link
G STAT1 signal transducer and activator of transcription 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29147627 NCBI chr37:1,513,438...1,549,837
Ensembl chr37:1,507,219...1,550,178 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 treatment ISO associated with Melanoma
CTD Direct Evidence: marker/mechanism
associated with Prostatic Neoplasms;protein:decreased activity
associated with Carcinoma, Renal Cell;protein:increased phosphorylation		 RGD
CTD		 PMID:12131365 PMID:16540670 PMID:17382154 PMID:21937440 PMID:23382965 More... RGD:2291915 RGD:2291917 RGD:8694303 NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672 		JBrowse link
G STAT5A signal transducer and activator of transcription 5A disease_progression ISO DNA:CNV: :prostate (human) RGD PMID:23660011 RGD:151667415 NCBI chr 9:20,616,041...20,638,523
Ensembl chr 9:20,617,151...20,638,103 		JBrowse link
G STIM1 stromal interaction molecule 1 ameliorates
exacerbates
treatment		 ISO associated with hepatocellular carcinoma; human cells in mouse model
associated with nasopharynx carcinoma; human cells in mouse model
associated with hepatocellular carcinoma;protein:decreased expression:liver (human)
associated with stomach cancer; human cells in mouse model
human cells in mouse model;associated with lung cancer		 RGD PMID:27431311 PMID:28713917 PMID:32165272 PMID:32483465 RGD:152995357 RGD:152995361 RGD:152995387 RGD:152995400 NCBI chr21:26,394,592...26,594,764
Ensembl chr21:26,394,811...26,593,375 		JBrowse link
G TBCB tubulin folding cofactor B ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr 1:116,576,222...116,585,788
Ensembl chr 1:116,576,219...116,586,021 		JBrowse link
G TCF3 transcription factor 3 disease_progression ISO associated with colon cancer RGD PMID:26212009 RGD:11533019 NCBI chr20:57,255,091...57,284,223
Ensembl chr20:57,254,384...57,283,981 		JBrowse link
G TCL1B TCL1 family AKT coactivator B ISO CTD Direct Evidence: marker/mechanism CTD PMID:20228224 NCBI chr 8:64,497,560...64,500,412
Ensembl chr 8:64,497,560...64,500,412 		JBrowse link
G TET2 tet methylcytosine dioxygenase 2 ISO associated with colorectal cancer; protein:decreased expression:colorectum (human) RGD PMID:33552282 RGD:150429609 NCBI chr32:26,021,745...26,145,109
Ensembl chr32:26,059,693...26,143,536 		JBrowse link
G TFPI2 tissue factor pathway inhibitor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17372906 NCBI chr14:19,399,259...19,403,890
Ensembl chr14:19,399,720...19,403,708 		JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 ISO associated with Mammary Neoplasms, Experimental RGD PMID:12808151 RGD:737735 NCBI chr11:56,191,383...56,223,042
Ensembl chr11:56,161,772...56,218,594 		JBrowse link
G TGFBR2 transforming growth factor beta receptor 2 ISO CTD Direct Evidence: therapeutic
associated with Mammary Neoplasms, Experimental		 CTD
RGD		 PMID:12808151 PMID:16489006 RGD:737735 NCBI chr23:13,886,869...13,946,480
Ensembl chr23:13,889,000...13,977,636 		JBrowse link
G TGIF1 TGFB induced factor homeobox 1 ISO CTD Direct Evidence: therapeutic CTD PMID:29746904 NCBI chr 7:70,040,376...70,048,346
Ensembl chr 7:70,040,508...70,047,912 		JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 ISO associated with Breast Neoplasms;protein:increased expression:plasma RGD PMID:17407159 RGD:2290346 NCBI chr  X:41,201,623...41,205,314
Ensembl chr  X:41,201,638...41,205,310 		JBrowse link
G TIMP2 TIMP metallopeptidase inhibitor 2 ISO associated with Breast Neoplasms RGD PMID:17505812 RGD:2290394 NCBI chr 9:2,521,882...2,533,883
Ensembl chr 9:2,521,882...2,533,989 		JBrowse link
G TLR4 toll like receptor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22180778 NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165 		JBrowse link
G TNC tenascin C ISO associated with Carcinoma, Renal Cell;protein:increased expression:lung RGD PMID:16928692 RGD:4889612 NCBI chr11:69,077,532...69,169,673
Ensembl chr11:69,077,535...69,170,281 		JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:8032535 PMID:23431386 NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425 		JBrowse link
G TNFAIP8 TNF alpha induced protein 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21969086 NCBI chr11:8,624,106...8,685,389
Ensembl chr11:8,660,557...8,684,374 		JBrowse link
G TNFRSF11A TNF receptor superfamily member 11a ISO associated with Prostatic Neoplasms;protein:increased expression:bone, lymph node RGD PMID:16752412 RGD:2302322 NCBI chr 1:14,504,595...14,555,956
Ensembl chr 1:14,503,033...14,556,041 		JBrowse link
G TNFRSF11B TNF receptor superfamily member 11b ISO associated with Breast Neoplasms;protein:increased expression:serum RGD PMID:23167338 RGD:7205479 NCBI chr13:18,155,765...18,183,263
Ensembl chr13:18,156,367...18,183,444 		JBrowse link
G TNFSF10 TNF superfamily member 10 ISO CTD Direct Evidence: therapeutic CTD PMID:21209944 NCBI chr34:36,719,249...36,734,989
Ensembl chr34:36,670,849...36,735,060 		JBrowse link
G TP53 tumor protein p53 ISO associated with Sarcoma;
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:17949449 PMID:21854749 PMID:22009531 PMID:23873029 PMID:27137931 RGD:11075090 NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109 		JBrowse link
G TP63 tumor protein p63 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15875781 NCBI chr34:21,766,861...21,985,095
Ensembl chr34:21,766,496...21,983,046 		JBrowse link
G TPM4 tropomyosin 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr20:46,354,808...46,376,489
Ensembl chr20:46,355,736...46,376,425 		JBrowse link
G TTR transthyretin treatment ISO associated with oral squamous cell carcinoma;protein:decreased expression:blood serum, saliva (human)
associated with colorectal cancer
associated with colorectal adenocarcinoma;protein:decreased expression:colorectum (human)		 RGD PMID:20957082 PMID:28730771 PMID:33739034 RGD:151660505 RGD:151665158 RGD:151665163 NCBI chr 7:57,940,354...57,947,084
Ensembl chr 7:57,914,381...57,947,058 		JBrowse link
G TWIST1 twist family bHLH transcription factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19806464
G TXNDC5 thioredoxin domain containing 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr35:7,834,135...7,854,836
Ensembl chr35:7,834,331...7,854,852 		JBrowse link
G TYMS thymidylate synthetase disease_progression ISO associated with Gastrointestinal Neoplasms;DNA:SNPs: : RGD PMID:25677447 RGD:11081002 NCBI chr 7:67,487,927...67,497,747
Ensembl chr 7:67,487,927...67,497,747 		JBrowse link
G TYR tyrosinase no_association ISO associated with melanoma; RGD PMID:11092039 RGD:8694395 NCBI chr21:10,799,940...10,894,187
Ensembl chr21:10,799,940...10,894,191 		JBrowse link
G UCHL3 ubiquitin C-terminal hydrolase L3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr22:29,348,962...29,397,944
Ensembl chr22:29,348,706...29,407,965 		JBrowse link
G VCAM1 vascular cell adhesion molecule 1 ISO associated with Pancreatic Neoplasms;protein:increased expression:serum RGD PMID:12923961 RGD:2325163 NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933 		JBrowse link
G VDR vitamin D receptor ISO associated with breast cancer;DNA:SNP:intron: (rs1544410) (human) RGD PMID:9613456 RGD:8158057 NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470 		JBrowse link
G VEGFA vascular endothelial growth factor A ISO associated with Carcinoma, Renal Cell
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:15659795 PMID:18930813 PMID:19064974 PMID:20158913 RGD:2315468 NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965 		JBrowse link
G VIM vimentin treatment ISO CTD Direct Evidence: marker/mechanism
associated with stomach cancer; human cells in mouse model 		CTD
RGD		 PMID:17085005 PMID:27431311 RGD:152995400 NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466 		JBrowse link
G VIP vasoactive intestinal peptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:19189304 NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700 		JBrowse link
G XPC XPC complex subunit, DNA damage recognition and repair factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:27777383 NCBI chr20:4,299,644...4,328,826
Ensembl chr20:4,300,386...4,328,768 		JBrowse link
G XRCC1 X-ray repair cross complementing 1 susceptibility ISO associated with Neoplasms, Germ Cell and Embryonal;DNA:polymorphism: :p.R399Q RGD PMID:16596238 RGD:2302576 NCBI chr 1:111,548,719...111,571,816
Ensembl chr 1:111,548,719...111,571,816 		JBrowse link
G YAP1 Yes1 associated transcriptional regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:28114269 NCBI chr 5:29,394,760...29,495,977
Ensembl chr 5:29,394,541...29,496,251 		JBrowse link
G YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr 9:45,506,830...45,562,081
Ensembl chr 9:45,507,282...45,562,086 		JBrowse link
G ZFHX3 zinc finger homeobox 3 exacerbates ISO brain metastasis associated with lung adenocarcinoma;DNA:mutations:multiple (human) RGD PMID:33479213 RGD:151361170 NCBI chr 5:78,450,963...78,635,615
Ensembl chr 5:78,455,005...78,610,033 		JBrowse link
Bone Metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX12 arachidonate 12-lipoxygenase, 12S type ISO associated with Prostatic Neoplasms; RGD PMID:14669797 RGD:1578303 NCBI chr 5:32,026,193...32,038,698
Ensembl chr 5:31,882,501...32,038,119 		JBrowse link
G BRIP1 BRCA1 interacting helicase 1 ISO associated with Breast Neoplasms; human gene in a mouse model RGD PMID:22875853 RGD:11252149 NCBI chr 9:34,804,285...34,984,640
Ensembl chr 9:34,806,535...34,983,788 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 disease_progression ISO associated with hepatocellular carcinoma;protein:increased expression:liver (human) RGD PMID:19508713 RGD:152023653 NCBI chr19:38,874,650...38,877,740
Ensembl chr19:38,874,145...38,877,740 		JBrowse link
G ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1 ISO associated with Breast Neoplasms;mRNA:increased expression:bone element (human) RGD PMID:23861746 RGD:13204736 NCBI chr 1:251,985...322,081
Ensembl chr 1:252,103...322,718 		JBrowse link
G MIR34A microRNA mir-34a susceptibility ISO associated with hepatocellular carcinoma;miRNA:decreased expression:serum, bone RGD PMID:27893432 RGD:14694837 NCBI chr 5:62,485,832...62,485,897
Ensembl chr 5:62,485,832...62,485,897 		JBrowse link
G MMP13 matrix metallopeptidase 13 ISO associated with Carcinoma, Renal Cell; mRNA, protein:increased expression:bone (human) RGD PMID:18709334 RGD:2306080 NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121 		JBrowse link
G PDGFD platelet derived growth factor D ISO associated with prostate carcinoma RGD PMID:22158043 RGD:13506772 NCBI chr 5:27,863,739...28,092,376
Ensembl chr 5:27,863,591...28,089,936 		JBrowse link
Circulating Neoplastic Cells term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ERBB2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29044505 NCBI chr 9:22,760,373...22,785,367
Ensembl chr 9:22,759,256...22,785,294 		JBrowse link
Liver Metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACE angiotensin I converting enzyme ISO associated with colorectal cancer;mRNA:increased expression:liver (mouse) RGD PMID:20380732 RGD:25671446 NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358 		JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase severity ISO associated with skin melanoma;DNA:missense mutations:cds:
associated with colorectal cancer;DNA:missense mutation:cds:p.V600E (human)
associated with colorectal cancer;DNA:mutations:multiple
associated with colorectal cancer;DNA:mutation:cds:
associated with colorectal cancer;DNA:missense mutations:cds:pV599E,p.V600E (human)		 RGD PMID:22331825 PMID:23010994 PMID:26775732 PMID:27737491 PMID:28787433 RGD:11554843 RGD:14696791 RGD:15039394 RGD:18337264 RGD:18337265 NCBI chr16:8,222,909...8,318,179
Ensembl chr16:8,222,907...8,317,906 		JBrowse link
G CCL2 C-C motif chemokine ligand 2 disease_progression ISO associated with colorectal cancer RGD PMID:27058904 RGD:14995463 NCBI chr 9:39,008,187...39,009,932 JBrowse link
G CCL5 C-C motif chemokine ligand 5 treatment ISO associated with Animal Mammary Neoplasms; RGD PMID:15692764 RGD:14995455 NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852 		JBrowse link
G CCND2 cyclin D2 ISO associated with colorectal cancer;protein:increased expression:colorectum RGD PMID:19508551 RGD:151665111 NCBI chr27:40,563,306...40,593,362
Ensembl chr27:40,564,921...40,594,255 		JBrowse link
G CCNG1 cyclin G1 treatment ISO human cells in mouse model RGD PMID:10910035 RGD:151356987 NCBI chr 4:47,800,697...47,808,259
Ensembl chr 4:47,801,575...47,808,211 		JBrowse link
G CD44 CD44 molecule ISO associated with Breast Neoplasm;protein:increased expression:liver RGD PMID:17991717 RGD:2289349 NCBI chr18:32,735,493...32,826,483
Ensembl chr18:32,737,907...32,827,107 		JBrowse link
G CHD4 chromodomain helicase DNA binding protein 4 ameliorates ISO associated with human colon adenocarcinoma cells in a mouse model RGD PMID:28486105 RGD:153323299 NCBI chr27:38,411,009...38,440,367
Ensembl chr27:38,411,075...38,439,958 		JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 treatment ISO associated with colon carcinoma; RGD PMID:30381616 RGD:27095891 NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979 		JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 ameliorates ISO associated with colorectal cancer; human cells in mouse model RGD PMID:30789971 RGD:151893289 NCBI chr28:2,895,916...2,903,543 JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 ISO associated with colorectal cancer; human colon adenocarcinoma cells in a mouse model RGD PMID:29679563 RGD:26884358 NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 ameliorates ISO associated with colorectal cancer; human cells in mouse model
human cells in mouse model; associated with colorectal cancer		 RGD PMID:29436696 PMID:30789971 RGD:151893289 RGD:152023643 NCBI chr19:38,874,650...38,877,740
Ensembl chr19:38,874,145...38,877,740 		JBrowse link
G DAXX death domain associated protein exacerbates ISO associated with neuroendocrine tumor;DNA:mutations:CDS:multiple (human)
associated with colon cancer; mRNA:decreased expression:liver (human)
associated with pancreatic endocrine carcinoma;DNA:mutations:CDS:multiple (human)		 RGD PMID:30339629 PMID:30342802 PMID:31942198 RGD:152025194 RGD:152025199 RGD:152025203 NCBI chr12:2,755,960...2,760,687
Ensembl chr12:2,755,960...2,761,340 		JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 treatment ISO human cells in mouse model; nilotinib
mRNA:increased expression:liver (mouse)		 RGD PMID:29438985 PMID:30666650 PMID:33110221 RGD:151347537 RGD:151347685 RGD:151347840 NCBI chr12:653,800...671,190
Ensembl chr12:653,807...670,543 		JBrowse link
G DDR2 discoidin domain receptor tyrosine kinase 2 ameliorates ISO associated with colon carcinoma
associated with melanoma;		 RGD PMID:21701781 PMID:22071959 RGD:150429701 RGD:150429713 NCBI chr38:20,002,984...20,152,930
Ensembl chr38:20,008,057...20,152,275 		JBrowse link
G DOCK6 dedicator of cytokinesis 6 ameliorates ISO associated with stomach cancer; RGD PMID:29587866 RGD:155791564 NCBI chr20:50,029,354...50,066,829
Ensembl chr20:50,029,369...50,066,829 		JBrowse link
G FBXW7 F-box and WD repeat domain containing 7 disease_progression ISO associated with colorectal cancer; RGD PMID:28846828 RGD:21408566 NCBI chr15:50,187,579...50,417,188
Ensembl chr15:50,189,240...50,417,195 		JBrowse link
G FGFR1 fibroblast growth factor receptor 1 ISO associated with colorectal cancer;mRNA:increased expression:colorectal mucosa: RGD PMID:19082464 RGD:25330357 NCBI chr16:27,029,902...27,080,514
Ensembl chr16:27,031,588...27,078,261 		JBrowse link
G FOSL2 FOS like 2, AP-1 transcription factor subunit ISO human cells in mouse model RGD PMID:30114390 RGD:153344554 NCBI chr17:22,340,469...22,364,994
Ensembl chr17:22,341,322...22,361,772 		JBrowse link
G GPC3 glypican 3 ISO protein:increased expression:blood serum (human) RGD PMID:28801286 RGD:243065135 NCBI chr  X:104,313,426...104,751,215
Ensembl chr  X:104,313,591...104,751,756 		JBrowse link
G HMBS hydroxymethylbilane synthase ISO associated with colon adenocarcinoma;protein:decreased activity:liver(rat) RGD PMID:1386052 RGD:25440496 NCBI chr 5:14,767,306...14,775,205
Ensembl chr 5:14,767,666...14,775,082 		JBrowse link
G IL2 interleukin 2 treatment ISO associated with colon carcinoma
associated with Colorectal Neoplasms, Carcinoma, Hepatocellular;		 RGD PMID:9354462 PMID:11591892 RGD:14928215 RGD:8663446 NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394 		JBrowse link
G IQSEC1 IQ motif and Sec7 domain ArfGEF 1 ISO human cells in mouse model RGD PMID:22662237 RGD:153344589 NCBI chr20:3,241,058...3,403,394
Ensembl chr20:3,241,052...3,522,859 		JBrowse link
G MAP2K7 mitogen-activated protein kinase kinase 7 ISO associated with colon cancer;protein:increased expression:colon (human) RGD PMID:24533778 RGD:155259116 NCBI chr20:52,594,450...52,604,236
Ensembl chr20:52,594,536...52,602,150 		JBrowse link
G MIR148B microRNA mir-148b exacerbates ISO associated with stomach cancer; RGD PMID:29587866 RGD:155791564 NCBI chr27:975,146...975,206
Ensembl chr27:975,131...975,220 		JBrowse link
G MIR155 microRNA mir-155 ISO RGD PMID:26885061 RGD:21079444 NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833 		JBrowse link
G MIR200B microRNA mir-200b ISO associated with colorectal cancer;RNA:increased expression:liver: RGD PMID:28617555 RGD:14928321 NCBI chr 5:56,368,400...56,368,479
Ensembl chr 5:56,368,400...56,368,479 		JBrowse link
G MIR200C microRNA mir-200c ISO associated with colorectal cancer;RNA:increased expression:liver: RGD PMID:28617555 RGD:14928321 NCBI chr27:38,082,097...38,082,159
Ensembl chr27:38,082,091...38,082,169 		JBrowse link
G MIR223 microRNA mir-223 disease_progression ISO associated with colorectal cancer; RGD PMID:28846828 RGD:21408566 NCBI chr  X:50,838,131...50,838,233
Ensembl chr  X:50,838,131...50,838,233 		JBrowse link
G MIR494 microRNA mir-494 exacerbates ISO associated with pancreatic ductal adenocarcinoma; RGD PMID:24859161 RGD:156430321 NCBI chr 8:69,261,385...69,261,465
Ensembl chr 8:69,261,385...69,261,465 		JBrowse link
G MPL MPL proto-oncogene, thrombopoietin receptor exacerbates
severity		 ISO associated with pancreatic cancer; protein:increased expression:liver, pancreas (human)
associated with colorectal carcinoma;protein:increased expression:colorectum (human)
associated with pancreatic ductal adenocarcinoma; human cells in mouse model		 RGD PMID:23747337 PMID:30770989 RGD:126925751 RGD:126925752 NCBI chr15:16,815,102...16,825,321
Ensembl chr15:16,815,294...16,825,350 		JBrowse link
G NRAS NRAS proto-oncogene, GTPase susceptibility ISO associated with colorectal cancer;DNA:mutations:exons (human)
associated with melanoma;DNA:mutations: exons (human)
human gene in a mouse model;DNA:missense mutations:cds:p.G12V, p.Q61K (human)		 RGD PMID:26799184 PMID:28011498 PMID:28787433 RGD:14696774 RGD:14696791 RGD:14696792 NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788 		JBrowse link
G PTPRB protein tyrosine phosphatase receptor type B treatment ISO mouse tumor cells in mouse recipient RGD PMID:31348125 RGD:151660353 NCBI chr10:12,267,891...12,384,522
Ensembl chr10:12,241,716...12,384,435 		JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:30404068 RGD:152995463 NCBI chr 4:69,903,393...70,013,168
Ensembl chr 4:69,936,379...70,010,566 		JBrowse link
G RNF43 ring finger protein 43 ISO associated with colorectal adenocarcinoma;mRNA:increased expression:liver (human) RGD PMID:28789449 RGD:151361221 NCBI chr 9:32,996,668...33,061,781
Ensembl chr 9:32,997,937...33,060,313 		JBrowse link
G SLC3A2 solute carrier family 3 member 2 severity ISO associated with colon adenocarcinoma RGD PMID:11745822 RGD:151361130 NCBI chr18:53,810,468...53,819,021
Ensembl chr18:53,810,398...53,819,021 		JBrowse link
G SLC7A5 solute carrier family 7 member 5 severity ISO associated with colon adenocarcinoma
associated with colon cancer		 RGD PMID:11718450 PMID:11745822 RGD:151361129 RGD:151361130 NCBI chr 5:65,313,105...65,343,858
Ensembl chr 5:65,313,105...65,343,858 		JBrowse link
G SMAD4 SMAD family member 4 treatment ISO associated with colorectal carcinoma;protein:decreased expression:colorectum:
associated with colorectal carcinoma; DNA:mutations: :		 RGD PMID:17390050 PMID:29551247 RGD:18937000 RGD:21066338 NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405 		JBrowse link
G SOX30 SRY-box transcription factor 30 ameliorates ISO RGD PMID:29739711 RGD:151660333 NCBI chr 4:52,587,163...52,615,945
Ensembl chr 4:52,587,355...52,615,945 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase disease_progression ISO associated with colon cancer;protein:increased activity:colon RGD PMID:7678609 RGD:150521542 NCBI chr24:25,982,499...26,019,748
Ensembl chr24:25,999,048...26,018,077 		JBrowse link
G VEGFA vascular endothelial growth factor A ISO associated with colorectal carcinoma;mRNA,protein:increased expression:liver: RGD PMID:22156924 RGD:15014782 NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965 		JBrowse link
lung metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADAM28 ADAM metallopeptidase domain 28 ameliorates ISO associated with lung adenocarcinoma;
associated with lung carcinoma, breast carcinoma		 RGD PMID:22636800 PMID:26800504 RGD:11531771 RGD:153297785 NCBI chr25:33,092,645...33,147,791
Ensembl chr25:33,092,628...33,264,710 		JBrowse link
G ARHGAP5 Rho GTPase activating protein 5 ISO associated with Mammary Neoplasms, Experimental RGD PMID:20860838 RGD:126848767 NCBI chr 8:11,190,663...11,269,353
Ensembl chr 8:11,204,696...11,267,086 		JBrowse link
G ARID2 AT-rich interaction domain 2 exacerbates ISO associated with hepatocellular carcinoma, RGD PMID:32071245 RGD:150340708 NCBI chr27:8,411,092...8,579,735
Ensembl chr27:8,412,377...8,579,882 		JBrowse link
G AZGP1 alpha-2-glycoprotein 1, zinc-binding ameliorates ISO associated with hepatocellular carcinoma; RGD PMID:26902423 PMID:27993894 RGD:153350132 RGD:153350133 NCBI chr 6:9,622,991...9,629,154
Ensembl chr 6:9,622,992...9,629,154 		JBrowse link
G CA12 carbonic anhydrase 12 ameliorates ISO associated with breast cancer; RGD PMID:29786141 RGD:155226861 NCBI chr30:27,903,460...27,957,162
Ensembl chr30:27,905,837...27,957,742 		JBrowse link
G CBLB Cbl proto-oncogene B severity ISO associated with stomach carcinoma; RGD PMID:28334634 RGD:150540337 NCBI chr33:11,255,453...11,665,755
Ensembl chr33:11,199,863...11,530,810 		JBrowse link
G CCNG1 cyclin G1 ISO RGD PMID:30565428 RGD:151361205 NCBI chr 4:47,800,697...47,808,259
Ensembl chr 4:47,801,575...47,808,211 		JBrowse link
G CHD4 chromodomain helicase DNA binding protein 4 ameliorates ISO associated with human colon adenocarcinoma cells in a mouse model RGD PMID:28486105 RGD:153323299 NCBI chr27:38,411,009...38,440,367
Ensembl chr27:38,411,075...38,439,958 		JBrowse link
G COL10A1 collagen type X alpha 1 chain ameliorates ISO associated with H1299 cell RGD PMID:33324550 RGD:150429752 NCBI chr12:71,803,372...71,810,049
Ensembl chr12:71,798,692...71,809,399 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 ameliorates ISO associated with nasopharynx carcinoma; human cells in mouse model
associated with colorectal cancer; human cells in mouse model
associated with osteosarcoma and melanoma		 RGD PMID:16000558 PMID:18071913 PMID:26498029 PMID:31938138 RGD:151665329 RGD:151893515 RGD:152023752 RGD:152177473 NCBI chr19:38,874,650...38,877,740
Ensembl chr19:38,874,145...38,877,740 		JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 ISO RGD PMID:29483153 RGD:151347599 NCBI chr12:653,800...671,190
Ensembl chr12:653,807...670,543 		JBrowse link
G DDR2 discoidin domain receptor tyrosine kinase 2 exacerbates ISO associated with tongue squamous cell carcinoma; RGD PMID:24556606 RGD:150429746 NCBI chr38:20,002,984...20,152,930
Ensembl chr38:20,008,057...20,152,275 		JBrowse link
G FASN fatty acid synthase ISO associated with head and neck squamous cell carcinoma RGD PMID:20604875 RGD:126790467 NCBI chr 9:233,105...249,573
Ensembl chr 9:232,963...249,092 		JBrowse link
G FOSL2 FOS like 2, AP-1 transcription factor subunit ISO human cells in mouse model RGD PMID:30326930 RGD:153344557 NCBI chr17:22,340,469...22,364,994
Ensembl chr17:22,341,322...22,361,772 		JBrowse link
G HILPDA hypoxia inducible lipid droplet associated ISO human cells in mouse model RGD PMID:31142329 RGD:153344574 NCBI chr14:7,957,811...7,959,878 JBrowse link
G IQSEC1 IQ motif and Sec7 domain ArfGEF 1 ISO human cells in mouse model RGD PMID:18084281 RGD:153344604 NCBI chr20:3,241,058...3,403,394
Ensembl chr20:3,241,052...3,522,859 		JBrowse link
G ITGAV integrin subunit alpha V treatment ISO human cells in rat model RGD PMID:20841470 RGD:152998949 NCBI chr36:28,815,215...28,890,569
Ensembl chr36:28,804,013...28,887,430 		JBrowse link
G MAP3K1 mitogen-activated protein kinase kinase kinase 1 ameliorates ISO associated with breast carcinoma RGD PMID:16568086 RGD:150573808 NCBI chr 2:43,918,210...43,996,817
Ensembl chr 2:43,917,604...43,995,209 		JBrowse link
G MAP3K8 mitogen-activated protein kinase kinase kinase 8 ameliorates ISO associated with clear cell renal cell carcinoma RGD PMID:23982215 RGD:151356974 NCBI chr 2:16,717,845...16,740,816
Ensembl chr 2:16,720,596...16,740,515 		JBrowse link
G MIR423A microRNA mir-423a ISO human cells in mouse model RGD PMID:30326930 RGD:153344557 NCBI chr 9:44,155,913...44,155,971 JBrowse link
G MIR494 microRNA mir-494 ameliorates ISO associated with hepatocellular carcinoma RGD PMID:25820676 PMID:28055013 RGD:155900754 RGD:156430322 NCBI chr 8:69,261,385...69,261,465
Ensembl chr 8:69,261,385...69,261,465 		JBrowse link
G NF2 NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor ISO associated with hepatocellular carcinoma RGD PMID:26443326 RGD:11076529 NCBI chr26:22,816,869...22,896,103
Ensembl chr26:22,816,551...22,894,196 		JBrowse link
G NTRK3 neurotrophic receptor tyrosine kinase 3 ameliorates ISO associated with mammary carcinoma RGD PMID:20802235 RGD:150520014 NCBI chr 3:51,131,470...51,491,112
Ensembl chr 3:51,138,751...51,513,024 		JBrowse link
G PAGR1 PAXIP1 associated glutamate rich protein 1 ISO human cells in mouse model RGD PMID:33833989 RGD:153344568 NCBI chr 6:17,876,740...17,879,546 JBrowse link
G PTPRB protein tyrosine phosphatase receptor type B treatment ISO RGD PMID:23899555 RGD:151660352 NCBI chr10:12,267,891...12,384,522
Ensembl chr10:12,241,716...12,384,435 		JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 ISO human cells in mouse model RGD PMID:20978191 PMID:29809146 RGD:152995469 RGD:152995516 NCBI chr 4:69,903,393...70,013,168
Ensembl chr 4:69,936,379...70,010,566 		JBrowse link
G RPTOR regulatory associated protein of MTOR complex 1 ISO RGD PMID:29809146 RGD:152995516 NCBI chr 9:1,012,512...1,345,872
Ensembl chr 9:1,013,603...1,344,148 		JBrowse link
G SF3B4 splicing factor 3b subunit 4 ISO human cells in mouse model RGD PMID:30391496 RGD:155804298 NCBI chr17:59,208,989...59,214,643
Ensembl chr17:59,208,990...59,213,991 		JBrowse link
G SOX30 SRY-box transcription factor 30 ameliorates ISO RGD PMID:29739711 RGD:151660333 NCBI chr 4:52,587,163...52,615,945
Ensembl chr 4:52,587,355...52,615,945 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase treatment
ameliorates		 ISO associated with breast cancer;
associated with nasopharynx carcinoma;		 RGD PMID:15753384 PMID:27078847 RGD:150521726 RGD:1581400 NCBI chr24:25,982,499...26,019,748
Ensembl chr24:25,999,048...26,018,077 		JBrowse link
Lymphatic Metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA13 ATP binding cassette subfamily A member 13 susceptibility ISO DNA:amplification:cds: (human, male) RGD PMID:27366209 RGD:152995256 NCBI chr18:136,338...353,974
Ensembl chr18:135,690...352,871 		JBrowse link
G ADAM28 ADAM metallopeptidase domain 28 ISO associated with breast cancer;DNA:hypermethylation: RGD PMID:25620615 RGD:153298970 NCBI chr25:33,092,645...33,147,791
Ensembl chr25:33,092,628...33,264,710 		JBrowse link
G ADGRB1 adhesion G protein-coupled receptor B1 disease_progression ISO associated with stomach cancer; RGD PMID:11172604 RGD:13831357 NCBI chr13:36,627,791...36,649,013
Ensembl chr13:36,614,498...36,690,936 		JBrowse link
G AICDA activation induced cytidine deaminase ISO associated with stomach cancer;protein:increased expression:stomach (human) RGD PMID:21538122 RGD:127285638 NCBI chr27:37,064,107...37,073,791
Ensembl chr27:37,064,080...37,073,789 		JBrowse link
G ANGPTL4 angiopoietin like 4 ISO CTD Direct Evidence: therapeutic CTD PMID:17130448 NCBI chr20:52,942,090...52,948,126
Ensembl chr20:52,942,259...52,947,475 		JBrowse link
G ANXA1 annexin A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19381893 NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011 		JBrowse link
G AQP3 aquaporin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21401805 NCBI chr11:50,517,509...50,524,565 JBrowse link
G ARHGAP5 Rho GTPase activating protein 5 ISO associated with nasopharynx carcinoma;mRNA, protein:increased expression: epithelium of nasopharynx RGD PMID:25961434 RGD:11056278 NCBI chr 8:11,190,663...11,269,353
Ensembl chr 8:11,204,696...11,267,086 		JBrowse link
G ASXL1 ASXL transcriptional regulator 1 ISO associated with colorectal cancer RGD PMID:32317519 RGD:126779580 NCBI chr24:21,725,126...21,804,745
Ensembl chr24:21,661,059...21,802,815 		JBrowse link
G AXL AXL receptor tyrosine kinase ISO associated Pancreatic Neoplasms RGD PMID:19252414 RGD:2325833 NCBI chr 1:112,699,679...112,727,434
Ensembl chr 1:112,700,365...112,726,960 		JBrowse link
G BAG1 BAG cochaperone 1 disease_progression ISO associated with Breast Neoplasms:protein:increased expression:breast RGD PMID:18430249 RGD:2292908 NCBI chr11:50,348,833...50,363,532
Ensembl chr11:50,350,999...50,363,581 		JBrowse link
G BAMBI BMP and activin membrane bound inhibitor ISO associated with stomach cancer; protein:increased expression: : RGD PMID:24752577 RGD:14390158 NCBI chr 2:17,453,628...17,459,812
Ensembl chr 2:17,455,243...17,462,346 		JBrowse link
G BARHL2 BarH like homeobox 2 ISO associated with oral squamous cell carcinoma; mRNA:decreased expression:mouth mucosa RGD PMID:27542258 RGD:14390167 NCBI chr 6:57,971,077...57,977,197
Ensembl chr 6:57,971,018...57,977,211 		JBrowse link
G BCL2 BCL2 apoptosis regulator ISO associated with Breast Neoplasms;protein:increased expression:lymph node RGD PMID:18217456 RGD:2293013 NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658 		JBrowse link
G BIK BCL2 interacting killer ISO associated with cholangiocarcinoma;DNA:CNV:: RGD PMID:16865775 RGD:14394820 NCBI chr10:22,417,374...22,433,055 JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 disease_progression ISO associated with Breast Neoplasms
associated with Cervix Neoplasms;mRNA:splice variant		 RGD PMID:17285241 PMID:17877643 RGD:2293098 RGD:2293103 NCBI chr 9:2,930,308...2,959,307 JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29426936 NCBI chr16:8,222,909...8,318,179
Ensembl chr16:8,222,907...8,317,906 		JBrowse link
G BRD7 bromodomain containing 7 severity ISO protein:increased expression:lung: RGD PMID:22008115 RGD:9586442 NCBI chr 2:64,966,636...65,002,800
Ensembl chr 2:64,966,392...65,002,799 		JBrowse link
G BSG basigin disease_progression ISO associated with Breast Neoplasms RGD PMID:16004819 RGD:2289055 NCBI chr20:57,942,703...57,951,089
Ensembl chr20:57,943,276...57,951,061 		JBrowse link
G BTK Bruton tyrosine kinase disease_progression ISO associated with lung adenocarcinoma;protein:increased expression:lung (human) RGD PMID:31200752 RGD:151347847 NCBI chr  X:75,270,952...75,302,663
Ensembl chr  X:75,270,979...75,302,562 		JBrowse link
G CA9 carbonic anhydrase 9 ISO associated with Cervix Neoplasms RGD PMID:17233814 RGD:2293196 NCBI chr11:52,205,619...52,211,281
Ensembl chr11:52,205,668...52,211,267 		JBrowse link
G CAB39 calcium binding protein 39 ISO associated with pancreatic cancer;RNA:increased expression:pancreas RGD PMID:28197410 RGD:14398834 NCBI chr25:42,752,798...42,801,257
Ensembl chr25:42,703,332...42,799,279 		JBrowse link
G CASP9 caspase 9 ISO associated with Carcinoma, Non-Small-Cell Lung;DNA:SNP:exon:rs1052576 (human) RGD PMID:17285546 RGD:13434907 NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484 		JBrowse link
G CAV1 caveolin 1 disease_progression ISO associated with Melanoma RGD PMID:22134245 RGD:8661767 NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935 		JBrowse link
G CBL Cbl proto-oncogene ISO associated with stomach carcinoma;protein:increased expression:stomach RGD PMID:31611438 RGD:126925223 NCBI chr 5:14,600,409...14,676,974
Ensembl chr 5:14,607,013...14,676,956 		JBrowse link
G CBLB Cbl proto-oncogene B ISO associated with stomach carcinoma; RGD PMID:20038312 RGD:150540338 NCBI chr33:11,255,453...11,665,755
Ensembl chr33:11,199,863...11,530,810 		JBrowse link
G CCND2 cyclin D2 ISO associated with colorectal cancer;protein:increased expression:colorectum RGD PMID:19508551 RGD:151665111 NCBI chr27:40,563,306...40,593,362
Ensembl chr27:40,564,921...40,594,255 		JBrowse link
G CCNE1 cyclin E1 ISO associated with Carcinoma, Transitional Cell;protein:decreased expression RGD PMID:16949911 RGD:2289266 NCBI chr 1:121,688,622...121,697,533
Ensembl chr 1:121,688,796...121,697,649 		JBrowse link
G CCNH cyclin H ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 3:21,046,477...21,067,305
Ensembl chr 3:21,046,472...21,178,315 		JBrowse link
G CCR5 C-C motif chemokine receptor 5 ISO associated with Breast Neoplasms;mRNA:increased expression:lymph node RGD PMID:24301790 RGD:8551816 NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952 		JBrowse link
G CD274 CD274 molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:16530813 NCBI chr 1:93,461,735...93,605,772
Ensembl chr 1:93,585,518...93,603,522 		JBrowse link
G CD40 CD40 molecule ISO associated with breast cancer;DNA:snps:5' utr, intron:c.-1T>C, c.51+914T>G (rs1883832, rs4810485) (human) RGD PMID:21912605 RGD:8547780 NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301 		JBrowse link
G CD44 CD44 molecule ISO associated with Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms;mRNA, protein:splice variant, increased expression:breast, large intestine, stomach RGD PMID:16425351 RGD:2289356 NCBI chr18:32,735,493...32,826,483
Ensembl chr18:32,737,907...32,827,107 		JBrowse link
G CDH1 cadherin 1 ISO associated with Breast Neoplasms
associated with Cervix Neoplasms		 RGD PMID:17649807 PMID:18097581 RGD:2289498 RGD:2296046 NCBI chr 5:80,757,508...80,834,878
Ensembl chr 5:80,757,508...80,834,878 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A ISO associated with Eyelid Neoplasms;
associated with Oral Squamous Cell Carcinoma;		 RGD PMID:15817070 PMID:19628749 RGD:8661799 RGD:8662374 NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281 		JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B ISO associated with Breast Neoplasms
associated with non-small cell lung carcinoma		 RGD PMID:12015771 PMID:28601655 RGD:13673921 RGD:2293607 NCBI chr27:33,609,154...33,613,558
Ensembl chr27:33,611,760...33,612,906 		JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:29426936 NCBI chr11:41,223,316...41,226,056
Ensembl chr11:41,223,315...41,264,379 		JBrowse link
G CLDN1 claudin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33665778 NCBI chr34:22,303,058...22,319,101
Ensembl chr34:22,303,850...22,319,033 		JBrowse link
G CLPTM1L CLPTM1 like ISO associated with esophagus squamous cell carcinoma; mRNA:increased expression:esophagus RGD PMID:25480402 RGD:150530497 NCBI chr34:11,263,274...11,277,666
Ensembl chr34:11,263,162...11,277,436 		JBrowse link
G CLU clusterin ISO associated with breast cancer;DNA:snp:promoter:g.27611345C>G (rs9331888) (human) RGD PMID:22037783 RGD:8963167 NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563 		JBrowse link
G COMT catechol-O-methyltransferase ISO associated with breast cancer;DNA:missense mutation:cds:p.V108/158M (human) RGD PMID:10755383 RGD:8662330 NCBI chr26:29,359,930...29,381,854
Ensembl chr26:29,360,356...29,366,008 		JBrowse link
G CRP C-reactive protein susceptibility ISO associated with Breast Neoplasm; DNA:polymorphism: :1846C>T(rs1205)(human) RGD PMID:24633920 RGD:9580226 NCBI chr38:22,396,787...22,398,180
Ensembl chr38:22,396,263...22,399,166 		JBrowse link
G CSF1R colony stimulating factor 1 receptor ISO associated with Breast Neoplasms RGD PMID:14734466 RGD:2293711 NCBI chr 4:58,980,699...59,010,683
Ensembl chr 4:58,980,788...59,010,510 		JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 ISO associated with Prostatic Neoplasms RGD PMID:10611340 RGD:4891523 NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874 		JBrowse link
G CTNNA1 catenin alpha 1 ISO associated with Breast Neoplasms RGD PMID:12047765 RGD:2289795 NCBI chr11:26,273,322...26,459,497
Ensembl chr11:26,143,013...26,459,091 		JBrowse link
G CTNNB1 catenin beta 1 ISO associated with Breast Neoplasms;protein:decreased expression RGD PMID:17908479 RGD:2289813 NCBI chr23:10,559,722...10,572,933
Ensembl chr23:10,559,718...10,572,927 		JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 disease_progression ISO associated with stomach cancer;mRNA:increased expression:stomach (human) RGD PMID:21633638 RGD:152023624 NCBI chr28:2,895,916...2,903,543 JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 ISO associated with nasopharynx carcinoma; protein:increased expression:lymph node (human) RGD PMID:16000558 RGD:151893515 NCBI chr19:38,874,650...38,877,740
Ensembl chr19:38,874,145...38,877,740 		JBrowse link
G CYCS cytochrome c, somatic ISO associated with non-small cell lung carcinoma; protein:decreased expression:serum RGD PMID:25578497 RGD:13792769 NCBI chr14:38,579,446...38,581,983
Ensembl chr14:38,579,446...38,581,983 		JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 severity ISO mRNA, protein:increased expression:mouth (human)
mRNA:increased expression:kidney, lymph nodes (human)		 RGD PMID:27020590 PMID:31253192 RGD:151347620 RGD:151347863 NCBI chr12:653,800...671,190
Ensembl chr12:653,807...670,543 		JBrowse link
G DDR2 discoidin domain receptor tyrosine kinase 2 disease_progression ISO associated with oral squamous cell carcinoma RGD PMID:29945346 RGD:150429700 NCBI chr38:20,002,984...20,152,930
Ensembl chr38:20,008,057...20,152,275 		JBrowse link
G DNMT3B DNA methyltransferase 3 beta ISO associated with Carcinoma, Pancreatic Ductal; RGD PMID:22919364 RGD:9589121 NCBI chr24:22,096,386...22,123,378
Ensembl chr24:22,096,349...22,122,900 		JBrowse link
G EBAG9 estrogen receptor binding site associated antigen 9 ISO associated with Breast Neoplasms;protein:increased expression:breast
associated with Prostatic Neoplasm;protein:increased expression:prostate gland, lymph node		 RGD PMID:12054692 PMID:12845666 PMID:17187007 RGD:2289847 RGD:2289856 RGD:2298489 NCBI chr13:10,081,700...10,099,737
Ensembl chr13:10,081,695...10,099,501 		JBrowse link
G EGFR epidermal growth factor receptor treatment ISO associated with Squamous Cell Carcinoma of the Tongue RGD PMID:19380367 RGD:8551769 NCBI chr18:5,983,669...6,044,092
Ensembl chr18:5,982,770...6,042,631 		JBrowse link
G EHMT2 euchromatic histone lysine methyltransferase 2 ISO associated with Esophageal Squamous Cell Carcinoma;
associated with Melanoma;		 RGD PMID:24658378 PMID:24805087 RGD:9590069 RGD:9590071 NCBI chr12:1,341,202...1,354,602
Ensembl chr12:1,341,191...1,354,584 		JBrowse link
G EPHA2 EPH receptor A2 ISO protein:increased expression:esophagus (human) RGD PMID:33833989 RGD:153344568 NCBI chr 2:81,534,130...81,561,722
Ensembl chr 2:81,534,125...81,561,725 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 disease_progression ISO associated with Breast Neoplasms;DNA, protein:polymorphism, increased expression:serum:p.I655V
associated with lung adenocarcinoma; protein:increased expression:lung (human)
CTD Direct Evidence: marker/mechanism
associated with Carcinoma, Transitional Cell;protein:increased expression:urinary bladder		 RGD
CTD		 PMID:18097576 PMID:18237248 PMID:21532492 PMID:21966491 RGD:153344600 RGD:2289925 RGD:2289926 NCBI chr 9:22,760,373...22,785,367
Ensembl chr 9:22,759,256...22,785,294 		JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 ISO associated with Prostatic Neoplasms;protein:increased expression, altered localization:lymph node, nucleus
associated with head and neck squamous cell carcinoma		 RGD PMID:17634423 PMID:20604875 RGD:126790467 RGD:2289944 NCBI chr10:406,856...424,746
Ensembl chr10:406,633...424,264 		JBrowse link
G ERBB4 erb-b2 receptor tyrosine kinase 4 disease_progression
severity		 ISO associated with oral squamous cell carcinoma
associated with lung non-small cell carcinoma
associated with colorectal adenocarcinoma		 RGD PMID:16507107 PMID:21324275 PMID:27444519 RGD:126781762 RGD:126781766 RGD:126790471 NCBI chr37:19,029,647...20,134,576
Ensembl chr37:19,037,217...20,134,426 		JBrowse link
G FAS Fas cell surface death receptor susceptibility ISO associated with Cervix Neoplasms;DNA:polymorphism:promoter:-1377G>A RGD PMID:18068525 RGD:2298509 NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321 		JBrowse link
G FGF1 fibroblast growth factor 1 ISO associated with Cervix Neoplasms;mRNA:increased expression:lymph node RGD PMID:17242701 RGD:2290286 NCBI chr 2:37,467,431...37,554,770
Ensembl chr 2:37,470,985...37,554,619 		JBrowse link
G FGFR2 fibroblast growth factor receptor 2 ISO associated with breast cancer;DNA:snp:intron:c.109+7033T>A (rs1219648) (human) RGD PMID:20640597 RGD:7394846 NCBI chr28:31,303,882...31,411,015
Ensembl chr28:31,303,894...31,411,621 		JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 disease_progression ISO associated with Prostatic Neoplasms RGD PMID:14566827 RGD:2302210 NCBI chr25:11,551,372...11,670,891
Ensembl chr25:11,581,206...11,692,284 		JBrowse link
G FOXA1 forkhead box A1 ISO associated with lung non-small cell carcinoma; mRNA:increased expression: : RGD PMID:29115441 RGD:151665751 NCBI chr 8:16,072,629...16,083,105
Ensembl chr 8:16,079,140...16,083,807 		JBrowse link
G FOXP1 forkhead box P1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25485836 NCBI chr20:20,438,631...21,020,516
Ensembl chr20:20,788,433...21,016,397 		JBrowse link
G GPX3 glutathione peroxidase 3 ISO associated with stomach carcinoma; DNA:hypermethylation:promoter RGD PMID:23071548 RGD:151665353 NCBI chr 4:58,200,671...58,209,010
Ensembl chr 4:58,200,672...58,209,010 		JBrowse link
G GRIK2 glutamate ionotropic receptor kainate type subunit 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr12:58,932,754...59,991,305
Ensembl chr12:59,355,017...59,990,408 		JBrowse link
G HMGB1 high mobility group box 1 ISO associated with Adenocarcinoma, Colon RGD PMID:20616616 RGD:10402080 NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165 		JBrowse link
G ICAM1 intercellular adhesion molecule 1 ISO associated with Breast Neoplasms RGD PMID:21590495 RGD:8547712 NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914 		JBrowse link
G IER2 immediate early response 2 ISO RGD PMID:22120713 RGD:153323322 NCBI chr20:49,071,243...49,074,184
Ensembl chr20:49,072,234...49,072,902 		JBrowse link
G IL13 interleukin 13 ISO associated with Melanoma, Cutaneous Malignant;mRNA:increased expression:lymph node RGD PMID:17545514 RGD:8549587 NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388 		JBrowse link
G IL18 interleukin 18 ISO associated with Breast Neoplasms;protein:increased expression:serum RGD PMID:12902898 RGD:8655867 NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348 		JBrowse link
G ING4 inhibitor of growth family member 4 ISO CTD Direct Evidence: therapeutic CTD PMID:27806345 NCBI chr27:38,371,656...38,379,251
Ensembl chr27:38,371,766...38,379,029 		JBrowse link
G IQSEC1 IQ motif and Sec7 domain ArfGEF 1 disease_progression ISO associated with lung adenocarcinoma; protein:increased expression:lung (human) RGD PMID:21966491 RGD:153344600 NCBI chr20:3,241,058...3,403,394
Ensembl chr20:3,241,052...3,522,859 		JBrowse link
G ITGB1 integrin subunit beta 1 ISO associated with non-small cell lung carcinoma, RGD PMID:28537888 RGD:13792830 NCBI chr 2:3,728,472...3,757,696
Ensembl chr 2:3,670,596...3,756,961 		JBrowse link
G KCNJ12 potassium inwardly rectifying channel subfamily J member 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34755307 NCBI chr 5:42,819,412...42,860,916
Ensembl chr 5:42,850,372...42,860,899 		JBrowse link
G KDR kinase insert domain receptor treatment ISO associated with Squamous Cell Carcinoma of the Tongue RGD PMID:19380367 RGD:8551769 NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042 		JBrowse link
G KISS1 KiSS-1 metastasis suppressor ISO CTD Direct Evidence: therapeutic CTD PMID:21383688 NCBI chr38:768,333...774,328
Ensembl chr38:768,585...773,382 		JBrowse link
G KLF7 KLF transcription factor 7 ISO CTD Direct Evidence: therapeutic CTD PMID:37734194 NCBI chr37:15,515,563...15,607,345
Ensembl chr37:15,521,622...15,605,824 		JBrowse link
G KMT2D lysine methyltransferase 2D ISO associated with stomach cancer RGD PMID:30177394 RGD:150521710 NCBI chr27:5,516,866...5,556,303
Ensembl chr27:5,521,804...5,553,490 		JBrowse link
G LAMC2 laminin subunit gamma 2 ISO associated with lung squamous cell carcinoma; RGD PMID:23124251 RGD:13793371 NCBI chr 7:16,543,541...16,625,304
Ensembl chr 7:16,569,086...16,624,085 		JBrowse link
G LOC611363 mesothelin ISO CTD Direct Evidence: marker/mechanism CTD PMID:22644300 NCBI chr 6:39,827,985...39,834,945 JBrowse link
G LRRC59 leucine rich repeat containing 59 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 9:26,350,300...26,364,021
Ensembl chr 9:26,351,734...26,364,082 		JBrowse link
G MACIR macrophage immunometabolism regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 3:7,956,865...7,968,964 JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29426936 NCBI chr14:55,599,047...55,711,626
Ensembl chr14:55,598,337...55,724,027 		JBrowse link
G MIR125A microRNA mir-125a ISO associated with stomach cancer; RGD PMID:22322911 RGD:21408544 NCBI chr 1:105,400,273...105,400,332
Ensembl chr 1:105,400,270...105,400,337 		JBrowse link
G MIR152 microRNA mir-152 ISO associated with breast cancer RGD PMID:22935141 RGD:19165152 NCBI chr 9:24,335,161...24,335,219
Ensembl chr 9:24,335,146...24,335,225 		JBrowse link
G MIR155 microRNA mir-155 disease_progression ISO associated with colon cancer RGD PMID:26885061 PMID:27856635 PMID:29893326 RGD:21079444 RGD:21079446 RGD:21409756 NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833 		JBrowse link
G MIR187 microRNA mir-187 ISO associated with oral squamous cell carcinoma; RNA:increased expression:plasma RGD PMID:27542258 RGD:14390167 NCBI chr 7:54,261,943...54,262,010
Ensembl chr 7:54,261,943...54,262,010 		JBrowse link
G MIR224 microRNA mir-224 ISO associated with colorectal cancer; mRNA:decreased expression:colorectal mucosa: RGD PMID:25919696 RGD:14398749 NCBI chr  X:119,925,345...119,925,413
Ensembl chr  X:119,925,345...119,925,413 		JBrowse link
G MIR30A microRNA mir-30a ISO associated with Colorectal Neoplasms RGD PMID:23486085 RGD:13432035 NCBI chr12:33,783,894...33,783,956
Ensembl chr12:33,783,891...33,783,961 		JBrowse link
G MIR335 microRNA mir-335 ISO associated with stomach cancer; RNA:decreased expression:stomach RGD PMID:21822301 RGD:14394425 NCBI chr14:6,444,861...6,444,918
Ensembl chr14:6,444,847...6,444,932 		JBrowse link
G MIR432 microRNA mir-432 disease_progression ISO mRNA:decreased expression:colon (human) RGD PMID:33717244 RGD:152999433 NCBI chr 8:69,106,415...69,106,501
Ensembl chr 8:69,106,415...69,106,501 		JBrowse link
G MMP2 matrix metallopeptidase 2 disease_progression ISO associated with Carcinoma, Ductal, Breast
associated with Tongue Neoplasms		 RGD PMID:23107277 PMID:23280016 RGD:8547824 RGD:8655998 NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113 		JBrowse link
G MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) ISO associated with breast cancer;DNA:deletion:promoter:-1170_-1172delA (human) RGD PMID:15161710 RGD:8662937 NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222 		JBrowse link
G MMP9 matrix metallopeptidase 9 disease_progression ISO associated with Endometrial Neoplasms;protein:increased expression:endometrium
associated with Tongue Neoplasms
associated with Carcinoma, Non-Small-Cell Lung;protein:increased expression:serum		 RGD PMID:12487935 PMID:20704821 PMID:23107277 RGD:2298523 RGD:5129215 RGD:8547824 NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293 		JBrowse link
G MSH2 mutS homolog 2 ISO associated with laryngeal squamous cell carcinoma RGD PMID:24459922 RGD:126848797 NCBI chr10:49,517,448...49,594,001
Ensembl chr10:49,517,369...49,594,210 		JBrowse link
G MTA1 metastasis associated 1 ISO associated with Carcinoma, Non-Small-Cell Lung;mRNA:increased expression:lung RGD PMID:11804687 RGD:9588220 NCBI chr 8:72,752,894...72,772,236
Ensembl chr 8:72,753,178...72,772,762 		JBrowse link
G MTOR mechanistic target of rapamycin kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 2:84,818,893...84,939,283
Ensembl chr 2:84,787,708...84,939,114 		JBrowse link
G MUC1 mucin 1, cell surface associated ISO associated with Common Bile Duct Neoplasms
associated with Esophageal Neoplasms
associated with Gallbladder Neoplasms;protein:altered localization:gallbladder
associated with Carcinoma, Renal Cell;		 RGD PMID:10390012 PMID:11295067 PMID:16222735 PMID:21339746 RGD:2324649 RGD:2324860 RGD:7245968 RGD:7349383 NCBI chr 7:42,338,939...42,344,690
Ensembl chr 7:42,340,375...42,344,690 		JBrowse link
G MUC5AC mucin 5AC, oligomeric mucus/gel-forming ISO associated with chloangiocarcinoma;protein:increased expression:bile duct RGD PMID:16842244 RGD:2325168 NCBI chr18:45,471,232...45,498,961 JBrowse link
G NCAM1 neural cell adhesion molecule 1 ISO RGD PMID:10086383 RGD:2326067 NCBI chr 5:19,895,587...20,192,334
Ensembl chr 5:19,895,613...20,191,995 		JBrowse link
G NME1 non-metastatic cells 1, protein (NM23A) expressed in ISO associated with Cervix Neoplasms; associated with Endometrial Neoplasms
associated with Breast Neoplasms		 RGD PMID:8102131 PMID:8855975 PMID:9036878 RGD:2299061 RGD:2299062 RGD:2299077 NCBI chr 9:26,990,336...26,998,895
Ensembl chr 9:26,990,469...26,998,955 		JBrowse link
G NME2 non-metastatic cells 2, protein (NM23B) expressed in ISO associated with Cervix Neoplasms; associated with Endometrial Neoplasms RGD PMID:8855975 RGD:2299062 NCBI chr 9:27,002,114...27,005,740
Ensembl chr 9:27,001,733...27,015,934 		JBrowse link
G NOS3 nitric oxide synthase 3 susceptibility ISO associated with Breast Neoplasms;DNA:polymorphisms:promoter, exon:-786T>C,p.E298D (human) RGD PMID:17262178 RGD:2292070 NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277 		JBrowse link
G OGG1 8-oxoguanine DNA glycosylase ISO associated with breast cancer;DNA:missense mutation:cds:p.S326C (rs1052133) (human) RGD PMID:18977234 RGD:8657156 NCBI chr20:8,486,150...8,491,448
Ensembl chr20:8,480,005...8,491,264 		JBrowse link
G PAGR1 PAXIP1 associated glutamate rich protein 1 disease_progression ISO protein:decreased expression:esophagus (human) RGD PMID:33833989 RGD:153344568 NCBI chr 6:17,876,740...17,879,546 JBrowse link
G PDGFA platelet derived growth factor subunit A ISO associated with Breast Neoplasms;mRNA:increased expression:breast RGD PMID:8619189 RGD:2292155 NCBI chr 6:16,271,082...16,293,246
Ensembl chr 6:16,270,104...16,292,396 		JBrowse link
G PDGFB platelet derived growth factor subunit B ISO associated with Breast Neoplasms;mRNA:increased expression:lymph node RGD PMID:17674348 RGD:2292173 NCBI chr10:25,798,877...25,819,422
Ensembl chr10:25,798,938...25,817,746 		JBrowse link
G PDPK1 3-phosphoinositide dependent protein kinase 1 ISO associated with non-small cell lung carcinoma;mRNA:increased expression:blood serum RGD PMID:25064732 RGD:13503320 NCBI chr 6:38,426,464...38,506,520
Ensembl chr 6:38,431,600...38,499,295 		JBrowse link
G PDPN podoplanin ISO associated with Breast Neoplasms
associated with Cervix Neoplasms		 RGD PMID:16528371 PMID:18165897 RGD:2292231 RGD:2292237 NCBI chr 2:83,552,735...83,581,375
Ensembl chr 2:83,552,830...83,581,375 		JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 ISO associated with Cervix Neoplasms
associated with Breast Neoplasms		 RGD PMID:16243812 PMID:18191186 RGD:2302867 RGD:2302868 NCBI chr26:14,522,124...14,526,370
Ensembl chr26:14,500,074...14,529,354 		JBrowse link
G PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha ISO associated with Colorectal Neoplasms RGD PMID:25550888 RGD:13432030 NCBI chr34:12,600,140...12,681,905
Ensembl chr34:12,600,233...12,675,910 		JBrowse link
G PIK3CB phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta ISO associated with Colorectal Neoplasms RGD PMID:25550888 RGD:13432030 NCBI chr23:34,832,661...34,955,410
Ensembl chr23:34,836,540...34,993,939 		JBrowse link
G PIP5K1A phosphatidylinositol-4-phosphate 5-kinase type 1 alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:34755307 NCBI chr17:60,257,017...60,295,866
Ensembl chr17:60,257,332...60,295,866 		JBrowse link
G POU5F1 POU class 5 homeobox 1 ISO associated with Seminoma; associated with Carcinoma, Embryonal RGD PMID:15386301 RGD:2292442
G PPARG peroxisome proliferator activated receptor gamma ISO associated with Cholangiocarcinoma;protein:increased expression:bile duct epithelium RGD PMID:20021832 RGD:2317459 NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981 		JBrowse link
G PREX1 phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 ISO associated with Prostatic Neoplasms RGD PMID:19305425 RGD:2314605 NCBI chr24:35,403,078...35,503,428
Ensembl chr24:35,404,564...35,582,041 		JBrowse link
G PTEN phosphatase and tensin homolog ISO associated with Breast Neoplasms
associated with Prostatic Neoplasms;protein:decreased expression:prostate		 RGD PMID:17163422 PMID:17919877 RGD:2292499 RGD:2292507 NCBI chr26:37,853,148...37,913,176
Ensembl chr26:37,835,661...37,913,176 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO associated with Breast Neoplasms
associated with Biliary Tract Neoplasms
associated with carcinoma, non-small-cell lung; DNA:SNP: :929G>C(human)		 RGD PMID:18159174 PMID:18353210 PMID:20016751 RGD:2300128 RGD:2317165 RGD:5135471 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903 		JBrowse link
G PTK2 protein tyrosine kinase 2 ISO associated with lung squamous cell carcinoma; protein:increased tyrosine phosphorylation:lymph node RGD PMID:23906871 RGD:152176664 NCBI chr13:35,302,439...35,541,336
Ensembl chr13:35,303,380...35,541,294 		JBrowse link
G PTPN13 protein tyrosine phosphatase non-receptor type 13 ISO associated with lung squamous cell carcinoma; protein:decreased expression:lymph node RGD PMID:23906871 RGD:152176664 NCBI chr32:10,125,447...10,328,764
Ensembl chr32:10,125,441...10,328,757 		JBrowse link
G RAMP2 receptor activity modifying protein 2 disease_progression ISO associated with colorectal cancer; protein:increased expression:lymph node (human) RGD PMID:23634287 RGD:151708733 NCBI chr 9:20,250,711...20,252,485 JBrowse link
G RAMP3 receptor activity modifying protein 3 ISO associated with colorectal cancer; protein:increased expression:lymph node (human) RGD PMID:23634287 RGD:151708733
G RASSF2 Ras association domain family member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17013896 NCBI chr24:16,736,786...16,779,910
Ensembl chr24:16,736,962...16,781,569 		JBrowse link
G RBM10 RNA binding motif protein 10 ISO associated with lung adenocarcinoma;DNA:missense mutation:exon:p.R241C (c.763C>T) (human) RGD PMID:30405763 RGD:151356993 NCBI chr  X:40,746,959...40,776,764
Ensembl chr  X:40,747,178...40,776,742 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO associated with Prostatic Neoplasms;protein:altered localization:nucleus, prostate gland RGD PMID:17020979 RGD:2298757 NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875 		JBrowse link
G RET ret proto-oncogene ISO associated with Pancreatic Neoplasms RGD PMID:18652760 RGD:2324925 NCBI chr28:3,946,132...3,995,505
Ensembl chr28:3,947,232...3,994,210 		JBrowse link
G RHOA ras homolog family member A ISO associated with Bladder Neoplasms;protein:increased expression:lymph node
associated with colorectal cancer		 RGD PMID:12855641 PMID:17597401 RGD:13432052 RGD:2298872 NCBI chr20:39,824,552...39,888,089
Ensembl chr20:39,824,575...39,887,215 		JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 ISO associated with breast ductal carcinoma; protein:increased expression:breast tumor, lymph node (human) RGD PMID:20978191 RGD:152995469 NCBI chr 4:69,903,393...70,013,168
Ensembl chr 4:69,936,379...70,010,566 		JBrowse link
G RUNX1 RUNX family transcription factor 1 ISO associated with Carcinoid Tumor RGD PMID:21636701 RGD:126779567 NCBI chr31:30,170,859...30,420,344
Ensembl chr31:30,170,605...30,420,839 		JBrowse link
G SFN stratifin ISO CTD Direct Evidence: marker/mechanism CTD PMID:19381893 NCBI chr 2:73,268,289...73,269,663
Ensembl chr 2:73,268,791...73,269,537 		JBrowse link
G SKP2 S-phase kinase associated protein 2 ISO associated with Endometrial Neoplasms;protein:increased expression:endometrium RGD PMID:16080017 RGD:2315043 NCBI chr 4:72,352,966...72,386,469
Ensembl chr 4:72,352,986...72,386,307 		JBrowse link
G SLC22A10 solute carrier family 22 member 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr18:53,597,148...53,628,569
Ensembl chr18:53,597,533...53,628,165 		JBrowse link
G SLC7A5 solute carrier family 7 member 5 severity ISO associated with gastric adenocarcinoma;protein:increased expression: :
associated with stomach carcinoma		 RGD PMID:21501294 PMID:25908107 RGD:11052781 RGD:151361203 NCBI chr 5:65,313,105...65,343,858
Ensembl chr 5:65,313,105...65,343,858 		JBrowse link
G SMAD4 SMAD family member 4 ISO associated with Breast Neoplasms RGD PMID:11809701 RGD:2300007 NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405 		JBrowse link
G SMO smoothened, frizzled class receptor ISO associated with colorectal cancer RGD PMID:30784110 RGD:150520177 NCBI chr14:7,518,871...7,527,703
Ensembl chr14:7,518,856...7,528,033 		JBrowse link
G SNCG synuclein gamma ISO RGD PMID:15221989 RGD:6478801 NCBI chr 4:34,604,867...34,608,851
Ensembl chr 4:34,605,091...34,608,842 		JBrowse link
G SOCS2 suppressor of cytokine signaling 2 ISO associated with Prostatic Neoplasms RGD PMID:16707422 RGD:2298925 NCBI chr15:33,761,434...33,788,973
Ensembl chr15:33,785,545...33,877,869 		JBrowse link
G SOCS3 suppressor of cytokine signaling 3 ISO associated with Breast Neoplasms RGD PMID:18097573 RGD:2298901 NCBI chr 9:2,859,267...2,859,944 JBrowse link
G SOD2 superoxide dismutase 2 disease_progression ISO CTD Direct Evidence: marker/mechanism
associated with tongue neoplasms;		 CTD
RGD		 PMID:10853026 PMID:19381893 PMID:20618948 RGD:8547519 NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706 		JBrowse link
G SOX2 SRY-box transcription factor 2 disease_progression ISO associated with Breast Neoplasms RGD PMID:24382260 RGD:8661670 NCBI chr34:14,853,000...14,855,153 JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase ISO associated with colon adenocarcinoma, RGD PMID:21282564 RGD:150520218 NCBI chr24:25,982,499...26,019,748
Ensembl chr24:25,999,048...26,018,077 		JBrowse link
G ST14 ST14 transmembrane serine protease matriptase ISO associated with Endometrial Neoplasms RGD PMID:19443387 RGD:2315087 NCBI chr 5:4,652,493...4,666,728
Ensembl chr 5:4,651,863...4,691,069 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21549414 NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672 		JBrowse link
G STK11 serine/threonine kinase 11 ISO associated with Breast Neoplasms;protein:decreased expression RGD PMID:12114407 RGD:2291948 NCBI chr20:57,558,966...57,579,163
Ensembl chr20:57,559,424...57,579,118 		JBrowse link
G TERT telomerase reverse transcriptase disease_progression ISO associated with lung non-small cell carcinoma; RGD PMID:11679180 RGD:152977755 NCBI chr34:11,288,622...11,307,790
Ensembl chr34:11,288,622...11,307,951 		JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 ISO associated with Endometrial Neoplasms;protein:increased expression:endometrium RGD PMID:12487935 RGD:2298523 NCBI chr  X:41,201,623...41,205,314
Ensembl chr  X:41,201,638...41,205,310 		JBrowse link
G TIMP3 TIMP metallopeptidase inhibitor 3 ISO associated with Breast Neoplasms;mRNA:increased expression:breast RGD PMID:12828172 RGD:2290437 NCBI chr10:30,627,154...30,681,520
Ensembl chr10:30,627,154...30,694,288 		JBrowse link
G TIMP4 TIMP metallopeptidase inhibitor 4 ISO associated with Breast Neoplasms;mRNA:increased expression:breast RGD PMID:12828172 RGD:2290437 NCBI chr20:6,399,522...6,405,089
Ensembl chr20:6,399,522...6,405,089 		JBrowse link
G TLR4 toll like receptor 4 ISO associated with Carcinoma, Ductal, Breast; RGD PMID:23338716 RGD:7794684 NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165 		JBrowse link
G TP53 tumor protein p53 ISO associated with Breast Neoplasms;DNA:missense mutation, duplication:cds, intron:p.R72P
associated with Penile Neoplasms
associated with Carcinoma, Squamous Cell;		 RGD PMID:18059331 PMID:18230179 PMID:18268397 RGD:2290533 RGD:2290534 RGD:8547790 NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109 		JBrowse link
G TP53BP1 tumor protein p53 binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr30:10,263,650...10,362,646
Ensembl chr30:10,263,650...10,336,134 		JBrowse link
G TRMT11 tRNA methyltransferase 11 homolog ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 1:64,861,404...64,917,449
Ensembl chr 1:64,834,770...65,064,562 		JBrowse link
G TSC2 TSC complex subunit 2 ISO associated with Breast Neoplasms RGD PMID:15951164 RGD:11568707 NCBI chr 6:38,865,509...38,898,977
Ensembl chr 6:38,865,507...38,898,960 		JBrowse link
G TSHR thyroid stimulating hormone receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9062474 NCBI chr 8:53,327,280...53,482,898
Ensembl chr 8:53,326,655...53,482,898 		JBrowse link
G TTR transthyretin ISO associated with colorectal cancer;protein:decreased expresion:blood serum (human) RGD PMID:21074777 RGD:151665155 NCBI chr 7:57,940,354...57,947,084
Ensembl chr 7:57,914,381...57,947,058 		JBrowse link
G VEGFA vascular endothelial growth factor A ISO associated with Breast neoplasms;
associated with Cervix Neoplasms		 RGD PMID:17597103 PMID:19783962 RGD:2315454 RGD:7421574 NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965 		JBrowse link
G VEGFC vascular endothelial growth factor C exacerbates
disease_progression		 ISO associated with Lymphatic Metastasis;
associated with pancreatic adenocarcinoma;protein:increased expression:pancreas (human)
associated with Breast Neoplasms
associated with Carcinoma, Transitional Cell;protein:increased expression:urinary bladder
associated with Prostatic Neoplasms
associated with thyroid diseases;mRNA:increased expression:thyroid gland:
associated with Cervix Neoplasms		 RGD PMID:12203051 PMID:15289890 PMID:17034609 PMID:18061373 PMID:19589137 More... RGD:155630642 RGD:2315469 RGD:2315474 RGD:2315475 RGD:2315484 RGD:7483611 RGD:7488946 NCBI chr16:52,883,242...52,987,684
Ensembl chr16:52,883,139...52,987,563 		JBrowse link
G VEGFD vascular endothelial growth factor D ISO associated with Breast Neoplasms
associated with Cervix Neoplasms		 RGD PMID:17951197 PMID:19589137 RGD:2315475 RGD:2315480 NCBI chr  X:11,590,097...11,627,199
Ensembl chr  X:11,590,089...11,626,486 		JBrowse link
G WRAP53 WD repeat containing antisense to TP53 ISO associated with esophagus squamous cell carcinoma;
associated with lung non-small cell carcinoma;		 RGD PMID:24626331 PMID:31281482 RGD:21081513 RGD:21081532 NCBI chr 5:32,574,153...32,586,222
Ensembl chr 5:32,574,134...32,594,333 		JBrowse link
Neoplasm Micrometastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYCS cytochrome c, somatic ISO associated with non-small cell lung carcinoma; protein:decreased expression:serum RGD PMID:25578497 RGD:13792769 NCBI chr14:38,579,446...38,581,983
Ensembl chr14:38,579,446...38,581,983 		JBrowse link
Neoplasm Seeding term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CDH1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27224422 NCBI chr 5:80,757,508...80,834,878
Ensembl chr 5:80,757,508...80,834,878 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  disease 15603
    disease of cellular proliferation 7286
      Neoplastic Processes 724
        Neoplasm Metastasis 493
          Bone Metastasis 7
          Circulating Neoplastic Cells 1
          Extranodal Extension 0
          Liver Metastasis 41
          Lymphatic Metastasis 161
          Neoplasm Micrometastasis 1
          Neoplasm Seeding 1
          Unknown Primary Neoplasms 0
          leptomeningeal metastasis 0
          lung metastasis 30
Path 2
Term Annotations click to browse term
  disease 15603
    Pathological Conditions, Signs and Symptoms 12033
      Pathologic Processes 7491
        Neoplastic Processes 724
          Neoplasm Metastasis 493
            Bone Metastasis 7
            Circulating Neoplastic Cells 1
            Extranodal Extension 0
            Liver Metastasis 41
            Lymphatic Metastasis 161
            Neoplasm Micrometastasis 1
            Neoplasm Seeding 1
            Unknown Primary Neoplasms 0
            leptomeningeal metastasis 0
            lung metastasis 30
paths to the root